This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Dental operations, only avohilmo
K11_DENTAL_OPER_ONLYAVO
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
278821 |
4. Check minimum number of eventsNone |
278821 |
5. Include endpointsNone |
278821 |
6. Filter based on genotype QC (FinnGen only) |
278821 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF7
Dental operations, only avohilmo
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 278821 | 175861 | 102960 |
| Unadjusted period prevalence (%) | 54.57 | 59.94 | 45.39 |
| Median age at first event (years) | 50.53 | 47.74 | 55.30 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1749
- Matched controls
- 13638
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A98
ICPC
Health maint/preventive medicine
14.2
323.0
1447
3431
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
38.3
323.0
760
268
Z01.2
ICD-10 Finland
Dental examination
35.0
323.0
646
224
SAA02
NOMESCO Finland
Basic examination of mouth
1458.1
323.0
1596
98
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
64.0
323.0
999
278
SDA02
NOMESCO Finland
Parodonthologic therapy
64.9
323.0
531
91
D82
ICPC
Teeth/gum disease
49.0
323.0
472
102
EBA00
NOMESCO Finland
Extraction of tooth
24.6
323.0
823
475
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
46.2
323.0
689
189
SAA01
NOMESCO Finland
Simple examination of mouth
31.6
323.0
1269
1052
-1
NOMESCO Finland
NA
26.9
323.0
605
263
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
24.0
323.0
912
592
K02.1
ICD-10 Finland
Caries of dentine
48.7
323.0
1102
460
VALMI
NOMESCO Finland
NA
84.5
323.0
482
61
WX110
NOMESCO Finland
Local anesthesy
19.4
323.0
1263
1611
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
40.0
323.0
597
174
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
46.2
323.0
428
95
KMAK
NOMESCO Finland
NA
26.7
323.0
997
645
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
71.8
323.0
400
56
SAA03
NOMESCO Finland
Extended examination of mouth
105.1
323.0
883
131
SFA10
NOMESCO Finland
Fillning on one surface of tooth
69.4
323.0
1133
351
EB1AA
NOMESCO Finland
Tooth X-ray examination
41.2
323.0
1027
454
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
33.0
319.4
456
144
N02BE01
ATC
paracetamol; systemic, rectal
10.7
317.4
1558
5890
WZA90
NOMESCO Finland
Other doctors statement
42.6
309.6
416
99
WX290
NOMESCO Finland
Other blockade of nerve
21.0
293.8
482
243
SFA40
NOMESCO Finland
Replacement of krone of tooth
30.3
288.6
421
141
SDA01
NOMESCO Finland
Simple parodonthologic therapy
45.9
284.8
377
81
WZB00
NOMESCO Finland
Telephone receipt or other advice
20.4
279.2
462
236
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
131.4
277.7
318
23
K04.5
ICD-10 Finland
Chronic apical periodontitis
20.8
274.3
450
223
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
47.2
260.5
343
70
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
12.4
253.6
523
454
EBA05
NOMESCO Finland
Complicated extraction of tooth
27.1
227.8
342
121
S18
ICPC
Laceration/cut
7.0
227.1
705
1201
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
12.4
218.5
446
367
D19
ICPC
Teeth/gum symptom/complaint
27.8
214.7
320
109
K03.64
ICD-10 Finland
Dental calculus supragingival
64.6
214.4
268
38
J01DB01
ATC
cefalexin; oral
5.4
211.5
1335
5111
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
52.7
208.9
270
47
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
15.7
191.3
347
212
SPAT1325
SPAT
Vaccination
5.3
183.0
727
1603
SPAT1263
SPAT
Sampling
5.1
179.8
768
1828
SPAT1256
SPAT
Intramuscular and subcutaneous injection
5.5
177.2
673
1398
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
111.1
172.3
202
16
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.4
165.1
851
2403
SFA00
NOMESCO Finland
Small filling
54.8
155.6
200
32
Z02.4
ICD-10 Finland
Examination for driving licence
6.6
153.3
468
719
SPAT1153
SPAT
Removal of sutures
6.4
147.2
460
725
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
5.5
146.1
528
997
A28
ICPC
Limited function/disability NOS
4.5
144.9
669
1644
L28
ICPC
Limited function/disability (L)
5.0
144.6
574
1204
K05.30
ICD-10 Finland
Periodontitis complex
34.4
142.0
200
51
SPAT1053
SPAT
Memory test
5.1
137.4
527
1055
P20
ICPC
Memory disturbance
5.2
135.8
511
999
SPAT1301
SPAT
No procedures
4.3
131.7
633
1588
SPAT1249
SPAT
Treatment-related counselling outside office
4.6
130.9
563
1264
SPAT1216
SPAT
Assessment of functional ability
5.0
130.4
515
1056
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
3.5
129.3
1118
4574
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
29.9
125.7
183
53
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
5.1
125.7
477
931
H13
ICPC
Plugged feeling ear
6.0
125.6
404
647
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
4.3
124.3
578
1391
I10
ICD-10 Finland
Essential (primary) hypertension
3.4
123.6
1188
5190
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
20.3
122.8
200
86
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
4.5
121.5
539
1234
J01CA04
ATC
amoxicillin; systemic
3.3
117.9
1183
5246
AA1AD
NOMESCO Finland
CT of head and brain
4.0
116.8
598
1558
SPAT1222
SPAT
Counselling/guidance promoting independent living
4.6
116.7
495
1077
SPAT1254
SPAT
Administration of medicine
4.4
113.2
502
1137
A02BC02
ATC
pantoprazole; systemic
3.2
111.6
1056
4404
N40
ICD-10 Finland
Hyperplasia of prostate
3.2
110.1
887
3285
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
29.5
109.0
159
46
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
5.6
108.5
368
619
H81
ICPC
Excessive ear wax
5.0
108.0
407
773
J01CE02
ATC
phenoxymethylpenicillin; oral
3.2
107.9
902
3415
EBA30
NOMESCO Finland
Excision of root of tooth
19.1
106.5
177
80
K08.3
ICD-10 Finland
Retained dental root
14.1
106.1
198
122
SPAT1310
SPAT
Counselling related to known health issue
4.9
106.1
409
795
L17
ICPC
Foot/toe symptom/complaint
5.9
105.9
341
537
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
4.3
103.6
471
1080
HMAK
NOMESCO Finland
NA
23.0
101.7
159
59
N02AJ06
ATC
codeine and paracetamol; systemic
6.1
101.7
319
484
M79.6
ICD-10 Finland
Pain in limb
4.2
99.2
459
1065
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
3.2
98.7
735
2513
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.4
97.1
629
1934
K05.31
ICD-10 Finland
Periodontitis pronounced
15.9
96.9
172
93
K02.2
ICD-10 Finland
Caries of cementum
40.4
95.7
130
27
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.4
95.3
597
1783
K03.66
ICD-10 Finland
Tooth plaque
62.7
95.3
120
16
SPAT1148
SPAT
Treatment of chronic ulcer or burn
4.5
91.9
385
804
SPAT1312
SPAT
General health counselling
4.6
91.3
375
767
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
4.7
90.5
360
712
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
5.2
90.2
320
558
M01AH05
ATC
etoricoxib; oral
3.6
89.8
514
1418
SPAT1149
SPAT
Suture or treatment of traumatic wound
5.7
88.8
292
465
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
3.3
87.8
594
1858
S29
ICPC
Skin symptom/complaint other
6.4
86.2
254
350
R23.8
ICD-10 Finland
Other and unspecified skin changes
6.7
86.1
245
322
H25.1
ICD-10 Finland
Senile nuclear cataract
2.8
85.9
932
3968
M54.5
ICD-10 Finland
Low back pain
4.2
85.1
383
851
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
11.7
83.7
169
123
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
16.2
83.2
146
76
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
45.6
83.0
110
20
A29
ICPC
General symptom/complaint other
5.2
82.9
292
502
SDE04
NOMESCO Finland
Periodontal treatment by dental hygienist, very extensive
61.6
82.4
104
14
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
41.5
81.5
110
22
L57.0
ICD-10 Finland
Actinic keratosis
4.6
81.0
324
638
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
23.6
80.1
124
44
SGA01
NOMESCO Finland
Tooth opening as first aid
28.1
80.1
118
35
A04
ICPC
Weakness/tiredness general
4.2
79.7
353
768
C10AA01
ATC
simvastatin; oral
2.7
79.1
955
4254
B01AB05
ATC
enoxaparin; parenteral
3.4
77.3
456
1266
WX320
NOMESCO Finland
Spinalanesthesy
3.9
76.3
376
899
SFC92
NOMESCO Finland
Other demanding adjuvant procedure of filling therapy
30.4
76.2
110
30
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
4.4
76.1
322
668
H02
ICPC
Hearing complaint
5.5
74.8
252
408
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.9
74.3
364
864
SPAT1262
SPAT
Handing over of treatment supplies
4.1
73.4
339
762
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
19.2
72.8
120
52
XKD00
NOMESCO Finland
Uroflowmetry
3.1
72.4
505
1576
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.6
72.0
781
3211
S02.51
ICD-10 Finland
Fracture of tooth, open
32.4
71.7
102
26
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
7.9
71.7
181
197
G04CA02
ATC
tamsulosin; oral
2.5
71.2
885
3922
R05
ICPC
Cough
5.1
71.0
253
436
SPAT1260
SPAT
Consultation of another employee
4.7
69.5
268
503
L15
ICPC
Knee symptom/complaint
6.7
69.2
195
250
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
13.9
68.7
128
77
B01AF02
ATC
apixaban; oral
5.1
68.7
244
418
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.7
68.4
629
2329
L03
ICPC
Low back symptom/complaint
5.8
68.3
218
329
SPAT1097
SPAT
Recording of ECG
4.6
68.2
269
516
K78
ICPC
Atrial fibrillation/flutter
4.5
68.0
278
553
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.9
68.0
327
758
Z3231
NOMESCO Finland
Registered nurse
2.8
67.2
550
1893
K04.1
ICD-10 Finland
Necrosis of pulp
24.8
67.0
102
34
L13
ICPC
Hip symptom/complaint
5.9
66.9
210
310
A97
ICPC
No disease
5.3
66.7
229
377
K02
ICD-10 Finland
Dental caries
27.8
66.5
98
29
C10AA05
ATC
atorvastatin; oral
2.7
64.7
587
2141
ECB00
NOMESCO Finland
Suture of gingiva
26.3
64.2
96
30
S21
ICPC
Skin texture symptom/complaint
6.5
63.3
182
239
R42
ICD-10 Finland
Dizziness and giddiness
2.9
63.0
503
1690
L82
ICD-10 Finland
Seborrhoeic keratosis
5.2
62.6
219
367
G04CA52
ATC
tamsulosin and dutasteride; systemic
4.1
62.3
281
611
L08
ICPC
Shoulder symptom/complaint
6.2
61.8
185
256
E0000UV
ATC
NA
2.6
61.6
584
2172
WX002
NOMESCO Finland
Sedation and analgesia
4.0
61.6
288
647
N17
ICPC
Vertigo/dizziness
5.2
61.3
215
361
C08CA01
ATC
amlodipine; oral
2.5
61.0
685
2799
B01AF01
ATC
rivaroxaban; oral
6.6
60.9
174
226
SGC00
NOMESCO Finland
Local medication of root channels of tooth
31.9
60.4
86
22
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.4
60.1
832
3780
C07AB07
ATC
bisoprolol; oral
2.3
59.7
1023
5156
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
2.6
58.6
566
2118
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
17.2
58.5
100
48
K05.3
ICD-10 Finland
Chronic periodontitis
38.4
58.5
80
17
ZXA05
NOMESCO Finland
Left side
2.6
57.6
540
1981
SPAT1229
SPAT
Assessment of need for aid
4.2
57.1
246
510
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.5
57.0
317
819
M17.1
ICD-10 Finland
Other primary gonarthrosis
3.4
56.9
324
853
K02.0
ICD-10 Finland
Caries limited to enamel
31.4
56.7
81
21
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.9
56.2
434
1411
SGC10
NOMESCO Finland
Covering pulpa of tooth
36.9
55.9
77
17
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.5
55.6
578
2237
M01AX05
ATC
glucosamine; oral
3.0
55.5
381
1146
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
3.7
55.3
275
648
T90
ICPC
Diabetes non-insulin dependent
3.4
55.1
312
815
Z2221
NOMESCO Finland
Medical doctor
2.7
54.7
455
1548
R53
ICD-10 Finland
Malaise and fatigue
2.6
54.6
529
1965
SPF30
NOMESCO Finland
Soling for prothesis
20.9
54.5
87
34
M25.5
ICD-10 Finland
Pain in joint
4.3
54.2
225
449
Z71.8
ICD-10 Finland
Other specified counselling
4.1
54.1
240
510
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
4.0
54.1
250
552
G04BD12
ATC
mirabegron; oral
5.8
54.0
169
247
ZXA00
NOMESCO Finland
Right side
2.5
53.2
545
2084
EBA10
NOMESCO Finland
Surgical removal of tooth
9.8
53.0
116
98
215
Kela drug reimbursment
Diabetes, non-insulin-treated
3.6
53.0
273
661
R07.4
ICD-10 Finland
Chest pain, unspecified
2.7
52.9
440
1493
K85
ICPC
Elevated blood pressure
4.2
52.8
225
460
SPAT1043
SPAT
Audiometry
4.9
52.5
192
336
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.8
51.9
395
1266
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
3.5
51.5
282
714
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
5.3
51.5
175
282
SPAT1252
SPAT
Overall medication plan or its review
4.4
51.3
209
409
Z00.0
ICD-10 Finland
General medical examination
3.3
51.1
302
812
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
14.5
50.6
92
52
R60.0
ICD-10 Finland
Localized oedema
3.8
50.4
243
555
H29
ICPC
Ear symptom/complaint other
5.6
50.2
161
242
EBA15
NOMESCO Finland
Extraction of large number of teeth
10.4
50.1
106
84
R4110
NOMESCO Finland
Physiotherapy
2.8
49.6
390
1270
SPAT1304
SPAT
Counselling and guidance related to ageing
4.2
49.6
209
422
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.6
48.4
254
622
U02
ICPC
Urinary frequency/urgency
6.1
48.4
145
200
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.2
48.2
820
3963
WX100
NOMESCO Finland
Conjunctival surface anesthesia
4.0
48.2
219
474
R02
ICPC
Shortness of breath/dyspnoea
4.2
48.0
205
419
M75.1
ICD-10 Finland
Rotator cuff syndrome
4.0
47.7
212
449
SPAT1211
SPAT
Application of soft bandage
4.7
47.6
178
318
K05.1
ICD-10 Finland
Chronic gingivitis
60.5
47.6
60
8
NF1AA
NOMESCO Finland
Hip X-ray examination
4.0
47.4
216
468
N06DX01
ATC
memantine; oral
2.8
47.3
372
1207
Z01.1
ICD-10 Finland
Examination of ears and hearing
3.2
47.2
286
779
UKC02
NOMESCO Finland
Cystoscopy
2.5
47.0
486
1846
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
3.5
46.1
243
596
Z97.2
ICD-10 Finland
Presence of dental prosthetic device (complete)(partial)
16.3
45.0
78
39
N06AX11
ATC
mirtazapine; oral
2.4
44.8
464
1756
D01BA02
ATC
terbinafine; oral; topical
2.9
44.5
320
980
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
3.6
44.4
227
542
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
5.5
44.3
143
216
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
44.2
331
1039
R05
ICD-10 Finland
Cough
3.6
43.8
220
517
SCA03
NOMESCO Finland
Preventive oral health care, extensive
23.6
43.7
67
23
G04CA01
ATC
alfuzosin; oral
2.7
43.3
352
1159
G04CB02
ATC
dutasteride; oral
3.3
43.3
248
647
L01
ICPC
Neck symptom/complaint
7.4
43.2
111
123
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
42.6
561
2382
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.6
42.0
211
496
M01AE01
ATC
ibuprofen; systemic, rectal
2.0
41.9
959
5128
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.5
41.7
218
529
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
3.7
41.6
205
474
ZXA10
NOMESCO Finland
Bilateral
2.7
41.5
340
1123
DFF00
NOMESCO Finland
Pure tone audiometry
5.3
41.5
138
216
SGA04
NOMESCO Finland
Very demanding opening and dilatation of root canal of tooth
27.3
41.5
61
18
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
40.6
289
874
SPE90
NOMESCO Finland
Other fitting and preparation of partial tooth prosthesis
26.9
40.6
60
18
NE1AA
NOMESCO Finland
Pelvis X-ray examination
4.0
40.5
178
372
SPAT1234
SPAT
Support of social functional capacity
3.9
40.2
186
407
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.4
40.2
422
1596
K86
ICPC
Hypertension uncomplicated
4.2
40.1
168
335
N02AA05
ATC
oxycodone; systemic
2.5
40.1
396
1449
SPAT1305
SPAT
Counselling and guidance related to physical exercise
4.0
39.7
174
362
SAA04
NOMESCO Finland
Special inverstigation of mouth
22.3
39.3
61
22
R01AD12
ATC
fluticasone furoate; nasal
4.6
39.1
150
274
SPAT1245
SPAT
Provision of support and information to patient’s family members
3.7
39.1
193
446
R01AD09
ATC
mometasone; nasal
2.5
38.9
357
1253
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.4
38.7
214
541
WZA00
NOMESCO Finland
Short statement of of health and health related matters
22.0
38.4
60
22
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
14.2
38.4
70
40
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
24.6
38.4
58
19
L12
ICPC
Hand/finger symptom/complaint
5.1
38.4
133
218
C09AA05
ATC
ramipril; oral
2.1
38.2
573
2550
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
4.8
38.2
138
237
M16.1
ICD-10 Finland
Other primary coxarthrosis
3.1
37.6
235
647
ZXC50
NOMESCO Finland
Cryotherapy
6.9
37.3
100
118
ZXE00
NOMESCO Finland
One hour or less
2.1
36.9
591
2695
SPAT1360
SPAT
Extensive global examination
4.0
36.9
161
333
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
5.2
36.9
124
196
B01AC04
ATC
clopidogrel; oral
2.4
36.7
388
1463
-44
ICPC
Preventive immunization/medic
4.1
36.2
154
311
SPAT1100
SPAT
Long-term monitoring of blood pressure
3.3
35.9
202
515
SPF40
NOMESCO Finland
Removal and reattachment with cement of tooth crone or short bridge
33.4
35.7
50
12
A99
ICPC
Disease/condition unspecnature/site
4.5
35.7
139
258
Z51.5
ICD-10 Finland
Palliative care
3.9
35.6
163
352
S82
ICPC
Naevus/mole
5.4
35.5
115
174
M01AB05
ATC
diclofenac; systemic, rectal
2.0
35.5
719
3584
U04
ICPC
Incontinence urine
4.8
35.3
127
217
A01
ICPC
Pain general/multiple sites
4.7
35.2
130
228
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
4.5
35.2
136
250
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
3.6
35.2
179
423
-31
ICPC
Medical examin/health eval partial
4.4
35.1
140
266
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
3.4
35.0
187
459
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
26.1
35.0
52
16
J01MA02
ATC
ciprofloxacin; systemic
1.9
35.0
735
3707
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
3.6
34.5
172
400
M70.6
ICD-10 Finland
Trochanteric bursitis
5.8
34.4
106
151
A03
ICPC
Fever
4.1
34.3
146
295
H26.4
ICD-10 Finland
After-cataract
2.7
34.2
274
886
A44
ICPC
General and Unspecified, Preventive immunization/medic
5.3
34.1
113
176
K07
ICPC
Swollen ankles/oedema
5.3
34.1
113
176
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
8.2
33.9
81
80
R31
ICD-10 Finland
Unspecified haematuria
2.4
33.9
329
1181
Y77
ICPC
Malignant neoplasm prostate
5.5
33.8
109
164
N30.0
ICD-10 Finland
Acute cystitis
2.8
33.6
253
786
H91.1
ICD-10 Finland
Presbycusis
2.8
33.5
247
758
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.7
33.5
261
828
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
5.3
33.5
111
173
S15
ICPC
Foreign body in skin
8.1
33.2
80
80
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.5
33.2
304
1057
DAX08
NOMESCO Finland
Fitting of hearing aid
4.9
33.2
118
199
X59
ICD-10 Finland
Exposure to unspecified factor
2.9
33.0
230
681
M03BX02
ATC
tizanidine; oral
2.2
32.8
427
1766
CJB10
NOMESCO Finland
Laser discission of secondary cataract
2.8
32.6
231
691
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.1
32.4
200
546
N03AX16
ATC
pregabalin; oral
2.5
32.1
283
963
D07AC01
ATC
betamethasone; topical
2.1
32.1
464
2003
A06AC01
ATC
ispaghula (psylla seeds); oral
2.2
32.1
402
1631
Z97.4
ICD-10 Finland
Presence of external hearing-aid
3.1
32.0
196
530
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
11.2
31.8
64
46
R52.9
ICD-10 Finland
Pain, unspecified
5.3
31.7
104
160
EMAK
NOMESCO Finland
NA
38.1
31.7
43
9
K08.80
ICD-10 Finland
Toothache NOS
19.5
31.6
51
21
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
2.7
31.6
238
739
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
31.6
454
1956
SFC00
NOMESCO Finland
Pillar of fillings material
41.9
31.5
42
8
A11
ICPC
Chest pain NOS
5.3
31.5
103
158
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
31.4
616
2996
P70
ICPC
Dementia
4.1
31.3
133
268
R06.0
ICD-10 Finland
Dyspnoea
2.1
31.2
431
1823
SPAT1212
SPAT
Extensive examination of musculoskeletal system
7.3
31.1
80
89
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
2.8
30.7
218
652
SPAT1101
SPAT
Orthostatic test
3.8
30.7
141
305
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
4.5
30.7
118
216
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
4.6
30.6
114
202
L05
ICPC
Flank/axilla symptom/complaint
7.5
30.6
77
83
I25
ICD-10 Finland
Chronic ischaemic heart disease
3.5
30.5
156
369
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.1
30.5
401
1658
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.9
30.5
208
605
DFF15
NOMESCO Finland
Speech audiometry
5.5
30.5
97
144
Z3226
NOMESCO Finland
Physiotherapist
2.4
30.4
292
1037
L02
ICPC
Back symptom/complaint
6.6
30.3
84
104
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.0
30.3
133
276
TUPEI
NOMESCO Finland
NA
60.6
30.3
38
5
K04.0
ICD-10 Finland
Pulpitis
17.0
30.2
51
24
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.7
30.2
231
723
K04.7
ICD-10 Finland
Periapical abscess without sinus
9.5
30.2
66
56
M54.4
ICD-10 Finland
Lumbago with sciatica
4.5
30.0
114
206
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
7.3
29.9
77
86
K05.18
ICD-10 Finland
Chronic gingivitis
44.4
29.6
39
7
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
6.4
29.5
83
105
J20
ICD-10 Finland
Acute bronchitis
4.4
29.5
117
221
UJF32
NOMESCO Finland
Coloscopy
2.2
29.4
367
1477
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
5.1
29.1
99
159
-60
ICPC
Result test/procedure
4.6
28.8
109
196
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.8
28.7
207
624
WZC30
NOMESCO Finland
Teaching
5.7
28.7
89
128
EB1AA
SPAT
NA
49.0
28.6
37
6
S06.0
ICD-10 Finland
Concussion
2.8
28.6
206
621
S12
ICPC
Insect bite/sting
7.6
28.6
71
75
SPC35
NOMESCO Finland
Production and attachment of single tooth bridge
90.0
28.5
34
*
K04.08
ICD-10 Finland
Other specified pulpit
31.8
28.4
40
10
SXC05
NOMESCO Finland
Other oral or dental procedure
22.0
28.4
44
16
AN1
HP
Coronary angiography
2.4
28.1
283
1028
U07
ICPC
Urine symptom/complaint other
4.9
28.1
98
162
L29
ICPC
Musculoskeletal sympt/complt other
4.8
27.8
99
167
S04
ICPC
Lump/swelling localized
5.5
27.8
88
130
R21
ICPC
Throat symptom/complaint
5.3
27.6
91
141
SDA05
NOMESCO Finland
Very demanding and lengthy parodonthologic therapy
87.3
27.6
33
*
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
2.2
27.4
315
1219
L14
ICPC
Leg/thigh symptom/complaint
5.1
27.4
93
149
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
3.9
27.4
121
253
S97
ICPC
Chronic ulcer skin
3.8
27.4
124
265
S02.53
ICD-10 Finland
Fracture of tooth root
26.6
27.2
40
12
Z3229
NOMESCO Finland
Other healthcare associate professional
2.7
27.1
212
671
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
3.4
26.9
142
344
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
3.1
26.8
166
452
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
9.9
26.8
57
46
L16
ICPC
Ankle symptom/complaint
5.3
26.8
88
136
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
3.4
26.6
143
352
K59.09
ICD-10 Finland
Constipation, unspecified
3.4
26.5
142
348
SCF01
NOMESCO Finland
Preventive oral care by dental hygienist or dental assistant, restricted
10.8
26.5
54
40
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
26.3
303
1171
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
26.2
320
1269
C03CA01
ATC
furosemide; systemic
1.7
26.1
1042
6266
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
3.1
26.1
155
409
A02BC05
ATC
esomeprazole; systemic
1.9
26.0
470
2185
Z01.8
ICD-10 Finland
Other specified special examinations
2.4
26.0
250
884
D11
ICPC
Diarrhoea
4.4
25.9
100
184
SPAT1281
SPAT
Other administrative function
4.2
25.9
105
203
M01AC06
ATC
meloxicam; systemic, rectal
2.0
25.8
392
1705
TQW99
NOMESCO Finland
Other minor procedure on skin
3.7
25.7
120
263
207
Kela drug reimbursment
Chronic arrhythmias
2.1
25.7
330
1339
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
4.1
25.6
109
220
Z02.7
ICD-10 Finland
Issue of medical certificate
3.8
25.5
118
257
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
4.8
25.4
91
155
K05.38
ICD-10 Finland
Other chronic periodontitis
22.2
25.3
39
14
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
7.2
25.2
65
73
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
3.4
25.2
131
314
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.6
25.1
121
273
SPAT1255
SPAT
Intravenous administration of medicine
3.7
25.0
118
261
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
114.8
24.9
29
*
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.7
24.9
193
606
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
24.9
319
1292
WX110
SPAT
NA
79.3
24.8
30
*
R74
ICPC
Upper respiratory infection acute
3.7
24.8
118
263
S19
ICPC
Skin injury other
5.4
24.8
80
121
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.5
24.7
209
689
F51.0
ICD-10 Finland
Nonorganic insomnia
4.2
24.6
99
190
SPAT1104
SPAT
Monitoring of emergency patient
3.4
24.6
127
303
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.8
24.5
111
237
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.3
24.4
136
343
M48.0
ICD-10 Finland
Spinal stenosis
2.5
24.3
212
711
M79.1
ICD-10 Finland
Myalgia
4.6
24.3
90
159
H25.8
ICD-10 Finland
Other senile cataract
2.1
24.3
317
1293
D01AE16
ATC
amorolfine; topical
2.8
23.5
169
506
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
2.3
23.4
250
930
R55
ICD-10 Finland
Syncope and collapse
2.2
23.3
270
1041
M54
ICD-10 Finland
Dorsalgia
3.9
23.3
102
212
R51.80
ICD-10 Finland
Headache
3.4
23.0
123
301
R83
ICPC
Respiratory infection other
4.2
23.0
94
183
U05
ICPC
Urination problems other
4.0
23.0
97
195
R35
ICD-10 Finland
Polyuria
3.4
22.9
122
298
G04BD08
ATC
solifenacin; oral
3.1
22.8
137
365
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
4.2
22.7
91
174
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
22.7
202
684
SPAT1167
SPAT
Insertion of urinary catheter
3.3
22.6
122
301
-50
ICPC
Medication/prescr/renewal
4.0
22.6
96
194
C61
ICD-10 Finland
Malignant neoplasm of prostate
2.0
22.5
339
1463
P06
ICPC
Sleep disturbance
5.6
22.4
69
99
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
0.4
22.4
87
1679
A46
ICD-10 Finland
Erysipelas
2.2
22.4
266
1037
-69
ICPC
Other reason for encounter NEC
4.4
22.4
86
158
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.5
22.3
172
2576
J01AA02
ATC
doxycycline; systemic
1.7
22.2
1090
6795
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
3.5
22.2
112
262
Z01.7
ICD-10 Finland
Laboratory examination
3.3
22.2
119
292
SCF02
NOMESCO Finland
Preventive oral care by dental hygienist
12.4
22.1
42
27
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.1
22.1
131
346
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
22.1
427
2018
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
22.0
251
959
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.8
22.0
150
435
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
5.0
21.9
75
122
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
2.7
21.9
163
499
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
4.4
21.8
85
158
Z76.0
ICD-10 Finland
Issue of repeat prescription
3.4
21.8
115
279
R96
ICPC
Asthma
5.1
21.8
73
116
K04.62
ICD-10 Finland
Periradicular abscess with fistula to mouth
33.9
21.8
30
7
R5140
NOMESCO Finland
Monitoring the use of the aid
3.2
21.7
121
305
SXA20
NOMESCO Finland
Local application of medicine to mouth
25.4
21.7
32
10
H60.9
ICD-10 Finland
Otitis externa, unspecified
6.8
21.5
57
67
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
4.2
21.3
85
162
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.0
21.3
330
1436
L04
ICPC
Chest symptom/complaint
7.4
21.2
53
57
M05BX04
ATC
denosumab; parenteral
5.2
21.2
69
106
F29
ICPC
Eye symptom/complaint other
4.8
21.0
74
124
SAB02
NOMESCO Finland
Oral and dental health check by dental hygienist or dental assistant
7.1
21.0
54
61
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
5.9
20.9
62
85
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
4.8
20.8
73
122
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
3.4
20.7
106
251
N05AH04
ATC
quetiapine; oral
2.2
20.7
236
900
R00.1
ICD-10 Finland
Bradycardia, unspecified
3.1
20.7
122
321
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
2.7
20.7
159
495
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
11.8
20.7
40
27
S01.0
ICD-10 Finland
Open wound of scalp
2.5
20.6
173
566
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
2.0
20.5
324
1417
G30.1
ICD-10 Finland
Alzheimer disease with late onset
2.0
20.5
308
1322
S01
ICPC
Pain/tenderness of skin
6.7
20.5
55
66
M03BC01
ATC
orphenadrine (citrate); systemic
3.1
20.5
121
319
C10AA07
ATC
rosuvastatin; oral
2.6
20.4
164
525
SPE01
NOMESCO Finland
Mucosa-supported partial denture
51.3
20.4
26
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.0
20.3
312
1351
S22
ICPC
Nail symptom/complaint
5.3
20.3
65
98
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
5.3
20.3
65
98
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
3.0
20.2
123
331
R07.3
ICD-10 Finland
Other chest pain
2.8
20.1
136
392
I50.9
ICD-10 Finland
Heart failure, unspecified
1.7
19.9
608
3292
N03AX12
ATC
gabapentin; oral
2.8
19.8
141
419
SGB30
NOMESCO Finland
Other demanding filling of root channel of tooth
20.5
19.8
31
12
J05AB01
ATC
aciclovir; systemic
2.1
19.6
243
963
A10BH01
ATC
sitagliptin; oral
2.8
19.6
137
404
D06BB10
ATC
imiquimod; topical
4.4
19.4
74
135
K03.1
ICD-10 Finland
Abrasion of teeth
90.8
19.4
23
*
R06AE07
ATC
cetirizine; oral
1.8
19.2
382
1809
JN4AD
NOMESCO Finland
Body CT examination
4.1
19.2
80
159
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
3.8
19.2
86
183
Z01.9
ICD-10 Finland
Special examination, unspecified
4.8
19.1
67
112
B81
ICPC
Anaemia vit B12/folate deficiency
3.6
19.1
93
212
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
6.2
19.1
54
70
M16
ICD-10 Finland
Coxarthrosis [arthrosis of hip]
4.5
19.0
71
127
C09CA01
ATC
losartan; oral
1.9
19.0
307
1351
K03.00
ICD-10 Finland
Approximal wear
34.2
19.0
26
6
K22
ICPC
Risk factor cardiovascular disease
4.7
18.9
68
117
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
18.9
346
1591
L90
ICPC
Osteoarthrosis of knee
5.9
18.9
55
74
J45
ICD-10 Finland
Asthma
3.8
18.8
85
182
D01
ICPC
Abdominal pain/cramps general
4.6
18.8
68
118
SPAT1172
SPAT
Guidance concerning hydration
3.6
18.7
90
203
TPH07
NOMESCO Finland
Cathetrisation of artery
2.6
18.7
150
478
B01AA03
ATC
warfarin; systemic
1.6
18.7
703
4009
JN4BD
NOMESCO Finland
Extensive body CT
2.8
18.7
132
392
SGB20
NOMESCO Finland
Filling of root of tooth with 2 root channels
20.9
18.7
29
11
R06AX27
ATC
desloratadine; oral
2.6
18.6
144
450
R81
ICPC
Pneumonia
4.6
18.6
68
119
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.8
18.6
127
368
K05
ICPC
Irregular heartbeat other
5.6
18.6
57
82
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.6
18.5
652
3650
XCK00
NOMESCO Finland
Perimetry
2.8
18.5
131
389
S16
ICPC
Bruise/contusion
5.3
18.5
59
89
K02.8
ICD-10 Finland
Other dental caries
16.4
18.4
31
15
K29
ICPC
Cardiovascular sympt/complt other
3.8
18.4
83
178
H61.2
ICD-10 Finland
Impacted cerumen
3.5
18.3
90
207
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.5
18.3
90
207
H03AA01
ATC
levothyroxine sodium; systemic
2.0
18.3
251
1036
K91
ICPC
Cerebrovascular disease
8.4
18.2
42
40
F16
ICPC
Eyelid symptom/complaint
7.2
18.2
46
51
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
4.0
17.9
75
150
H04.10
ICD-10 Finland
Dry eye syndrome
3.8
17.9
79
166
SPAT1139
SPAT
Nutrition survey
3.8
17.9
79
166
B82
ICPC
Anaemia other/unspecified
5.1
17.8
59
93
SBB10
NOMESCO Finland
Teeth copy
10.6
17.8
36
27
S02.59
ICD-10 Finland
Tooth fracture UNS
45.4
17.7
23
*
C08CA13
ATC
lercanidipine; oral
2.2
17.7
188
694
JN3AD
NOMESCO Finland
Abdominal CT examination
3.4
17.7
90
213
NFB40
NOMESCO Finland
Primary total prosthetic replacement of hip joint using hybrid technique
5.4
17.6
55
81
P01AB01
ATC
metronidazole; oral, rectal
1.8
17.6
389
1902
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
3.9
17.6
77
161
SPAT1251
SPAT
Organisation of medication
2.7
17.5
132
407
-62
ICPC
Administrative procedure
5.9
17.5
51
69
S54
ICPC
Skin, Repair/fix-suture/cast/prosth device
7.4
17.4
43
46
C09CA06
ATC
candesartan; oral
2.1
17.4
215
847
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
3.3
17.4
94
233
K77
ICPC
Heart failure
3.6
17.3
82
183
XJH00
NOMESCO Finland
Transanal ultrasonography
2.1
17.3
209
817
H84
ICPC
Presbyacusis
3.3
17.3
91
221
J01FA10
ATC
azithromycin; systemic
1.7
17.2
401
1991
H11.3
ICD-10 Finland
Conjunctival haemorrhage
5.1
17.2
57
90
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
5.1
17.2
57
90
X58
ICD-10 Finland
Exposure to other specified factors
2.7
17.2
125
376
S20
ICPC
Corn/callosity
8.2
17.2
40
39
A27
ICPC
Fear of other disease NOS
4.8
17.1
60
101
D07AC13
ATC
mometasone; topical
1.8
17.1
359
1724
SPAT1282
SPAT
Assessment of ability to drive and opinion
6.0
17.1
49
65
K03.0
ICD-10 Finland
Excessive attrition of teeth
36.3
17.0
23
5
S02.54
ICD-10 Finland
Fracture of both the crown and the root
36.3
17.0
23
5
S08
ICPC
Skin colour change
5.1
17.0
56
88
H04
ICPC
Ear discharge
4.9
17.0
58
95
SPAT1336
SPAT
Request for examination
4.9
17.0
58
95
L86
ICPC
Back syndrome with radiating pain
7.1
16.9
43
48
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
0.0
16.9
*
380
D12
ICPC
Constipation
4.1
16.9
69
135
SCF03
NOMESCO Finland
Preventive oral care by dental hygienist, extensive
24.7
16.9
25
8
R60.9
ICD-10 Finland
Oedema, unspecified
3.6
16.9
81
183
SPAT1081
SPAT
Cardiorespiratory global assessment
3.3
16.9
90
221
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
3.6
16.9
79
175
R03AC02
ATC
salbutamol; inhalant
1.6
16.9
592
3293
SPAT1141
SPAT
Excision of skin or mucous membrane lesion
5.4
16.8
53
79
A08
ICPC
Swelling
4.1
16.8
69
136
N06DA02
ATC
donepezil; oral
2.0
16.8
242
1017
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.6
16.8
713
4159
RD211
NOMESCO Finland
NA
7.3
16.8
42
46
R41.3
ICD-10 Finland
Other amnesia
3.6
16.8
79
176
K03.6
ICD-10 Finland
Deposits [accretions] on teeth
149.6
16.7
19
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
5.8
16.7
49
67
KED22
NOMESCO Finland
Transurethral resection of prostate
2.0
16.7
243
1025
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
2.6
16.6
134
429
SPAT1014
SPAT
Treatment of eyes
4.4
16.5
63
116
Z46.3
ICD-10 Finland
Fitting and adjustment of dental prosthetic device
14.3
16.5
29
16
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.8
16.4
114
334
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.6
16.4
128
403
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
16.4
276
1229
S01EE01
ATC
latanoprost; ophthalmic
2.3
16.3
167
605
M54.6
ICD-10 Finland
Pain in thoracic spine
5.8
16.3
48
66
K05.39
ICD-10 Finland
Periodontitis UNS
18.7
16.2
26
11
U71
ICPC
Cystitis/urinary infection other
4.4
16.2
61
111
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
34.7
16.2
22
5
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
2.9
16.1
104
290
116
Kela drug reimbursment
Prostate cancer
2.0
16.1
242
1033
SPAT1131
SPAT
Colonoscopy
6.0
16.1
46
61
F21
ICPC
NA
6.2
16.1
45
58
SPAT1285
SPAT
Provision of consultation response
3.9
16.1
70
146
Y06
ICPC
Prostate symptom/complaint
4.7
16.0
57
98
L11
ICPC
Wrist symptom/complaint
4.7
15.9
56
95
EBA00
SPAT
NA
52.4
15.8
20
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.6
15.8
57
99
S22.3
ICD-10 Finland
Fracture of rib
2.7
15.8
118
362
R01AD08
ATC
fluticasone; nasal
2.0
15.8
221
916
R33
ICD-10 Finland
Retention of urine
1.9
15.8
283
1288
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.9
15.7
257
1129
ZXD05
NOMESCO Finland
Urgent procedure
1.6
15.7
512
2782
ZZR00
NOMESCO Finland
Flap of skin
3.5
15.7
76
173
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
3.1
15.7
90
233
R03BB01
ATC
ipratropium bromide; inhalant
0.4
15.7
55
1116
XF404
NOMESCO Finland
Ambulatory ECG
2.6
15.7
123
387
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
2.8
15.7
104
297
FME20
NOMESCO Finland
Transvenous aortic valve replacement via femoral artery
9.7
15.7
33
27
TQW80
NOMESCO Finland
Local dermatologic skincare
6.6
15.7
42
51
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.9
15.6
98
270
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
4.8
15.6
54
90
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.8
15.6
304
1420
D07AB02
ATC
hydrocortisone butyrate; topical
1.7
15.5
351
1721
U28
ICPC
Limited function/disability (U)
6.2
15.5
43
55
M10
ICD-10 Finland
Gout
3.4
15.4
77
180
Z50.1
ICD-10 Finland
Other physical therapy
3.5
15.4
76
176
N01
ICPC
Headache
5.4
15.4
48
71
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
5.0
15.4
51
81
L03.0
ICD-10 Finland
Cellulitis of finger and toe
3.6
15.4
73
164
M54.2
ICD-10 Finland
Cervicalgia
4.8
15.4
53
88
B01AB10
ATC
tinzaparin; parenteral
3.6
15.4
72
160
K25
ICPC
Fear of hypertension
5.5
15.4
47
68
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
3.8
15.4
68
144
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.4
15.4
78
185
S01ED51
ATC
timolol, combinations; ophthalmic
2.1
15.3
188
737
XCK10
NOMESCO Finland
Photography of fundus of eye
2.2
15.3
165
613
SPA02
NOMESCO Finland
Preparation for dental prosthetics
33.1
15.3
21
5
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.5
15.3
129
422
UDC00
NOMESCO Finland
Ear microscopy
3.3
15.3
79
190
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
2.8
15.3
107
315
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
6.1
15.3
43
56
UJF30
NOMESCO Finland
Ileoscopy through colon
3.7
15.2
69
149
A60
ICPC
General and Unspecified, Result test/procedure
4.6
15.2
55
96
M01AE02
ATC
naproxen; oral, rectal
1.6
15.2
550
3066
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
5.4
15.2
47
69
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
5.0
15.2
50
79
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
2.5
15.1
126
411
WKPAL
NOMESCO Finland
NA
+∞
15.1
16
*
-54
ICPC
Repair/fix-suture/cast/prosth device
5.1
15.1
49
76
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.5
15.1
55
97
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.9
15.0
98
275
SPD00
NOMESCO Finland
Fitting and preparation of total teeth prosthesis
16.5
15.0
25
12
SDC10
NOMESCO Finland
Parodontological fixation
24.8
15.0
22
7
XX3DW
NOMESCO Finland
Time consuming IT work
3.5
14.9
73
168
SAD02
NOMESCO Finland
Assessment of need for oral health care, extensive
7.0
14.9
38
43
K04
ICPC
Palpitations/awareness of heart
7.0
14.9
38
43
L89
ICPC
Osteoarthrosis of hip
7.0
14.9
38
43
J05AB11
ATC
valaciclovir; oral
2.5
14.9
121
388
U06
ICPC
Haematuria
4.6
14.9
53
91
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
14.9
295
1383
M02AA07
ATC
piroxicam; topical
1.6
14.9
543
3029
Z29
ICPC
Social problem NOS
5.2
14.9
48
74
H53.1
ICD-10 Finland
Subjective visual disturbances
4.4
14.9
56
102
SCC01
NOMESCO Finland
Simple fluorination of mouth or other corresponding procedure
133.7
14.9
17
*
I50
ICD-10 Finland
Heart failure
2.4
14.9
130
436
K90
ICPC
Stroke/cerebrovascular accident
3.4
14.8
76
182
B01AE07
ATC
dabigatran etexilate; oral
4.2
14.8
58
110
H01
ICPC
Ear pain/earache
4.0
14.7
61
122
R04.0
ICD-10 Finland
Epistaxis
2.2
14.6
155
569
M15
ICD-10 Finland
Polyarthrosis
4.0
14.6
61
123
WX892
NOMESCO Finland
Monitored bed care
2.5
14.6
119
383
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
3.7
14.5
65
139
K76
ICPC
Ischaemic heart dis without angina
4.6
14.5
52
90
201
Kela drug reimbursment
Chronic cardiac insufficiency
0.4
14.5
85
1413
S01EE05
ATC
tafluprost; ophthalmic
4.7
14.5
51
87
M19.0
ICD-10 Finland
Primary arthrosis of other joints
3.8
14.4
63
132
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
4.6
14.4
52
91
S79
ICPC
Neoplasm skin benign/unspecified
7.5
14.4
35
37
A10BH05
ATC
linagliptin; oral
2.9
14.4
91
252
ZXD20
NOMESCO Finland
Day surgery
2.1
14.4
169
652
C05AA08
ATC
fluocortolone; rectal, topical
2.1
14.3
173
676
B02.9
ICD-10 Finland
Zoster without complication
3.0
14.3
85
225
L84
ICPC
Back syndrome without radiat pain
6.1
14.3
40
52
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.7
14.2
103
311
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
4.4
14.2
53
96
A91
ICPC
Abnormal result investigation NOS
4.8
14.1
48
79
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
4.1
14.1
56
108
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
4.0
14.0
58
116
SPAT1231
SPAT
Assessment of adjustments needed in living environment
3.7
14.0
64
140
K03.08
ICD-10 Finland
Other wear and tear of the teeth
66.9
13.9
17
*
A10BB01
ATC
glibenclamide; oral
0.4
13.9
79
1330
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
2.5
13.9
113
365
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.2
13.9
75
187
M35.3
ICD-10 Finland
Polymyalgia rheumatica
2.9
13.8
88
245
NF3AA
NOMESCO Finland
Femur X-ray examination
4.0
13.8
57
114
AN2
HP
Balloon angioplasty, including several vessels
3.5
13.8
67
154
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.3
13.8
133
469
L76
ICPC
Fracture: other
4.1
13.7
55
107
R5120
NOMESCO Finland
Preparation of an aid
3.3
13.6
72
177
S06
ICPC
Rash localized
4.0
13.6
56
112
G44.2
ICD-10 Finland
Tension-type headache
3.1
13.5
76
194
D20
ICPC
Mouth/tongue/lip symptom/complaint
6.8
13.5
35
41
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
6.5
13.5
36
44
R12
ICD-10 Finland
Heartburn
4.3
13.5
51
94
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
4.3
13.5
51
94
I95.1
ICD-10 Finland
Orthostatic hypotension
2.4
13.4
118
396
SPAT1058
SPAT
PEF monitoring instruction
4.4
13.4
50
91
B35.1
ICD-10 Finland
Tinea unguium
4.4
13.4
50
91
K80
ICPC
Cardiac arrhythmia NOS
4.1
13.4
54
106
XQ848
NOMESCO Finland
Dermatological photography
5.0
13.3
44
70
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
2.4
13.3
115
383
WX212
NOMESCO Finland
Femoral plexus blockade
4.0
13.3
55
110
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
6.9
13.3
34
39
SPAT1352
SPAT
Inspection, maintenance and instruction for use of hearing aid
3.6
13.3
62
138
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
0.3
13.2
30
737
R03DA04
ATC
theophylline; systemic, rectal
0.5
13.2
94
1466
R06
ICPC
Nose bleed/epistaxis
4.7
13.2
46
78
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
0.2
13.2
9
438
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
0.1
13.2
8
422
SPE00
NOMESCO Finland
Fitting and preparation of metal structure partial teeth prosthesis
18.4
13.2
21
9
SPAT1273
SPAT
Structured assessment of psychoactive substance / tobacco use
18.4
13.2
21
9
N05BA04
ATC
oxazepam; oral
1.6
13.1
392
2065
R03BA08
ATC
ciclesonide; inhalant
5.0
13.1
43
68
M53.0
ICD-10 Finland
Cervicocranial syndrome
4.8
13.1
45
75
H53.9
ICD-10 Finland
Visual disturbance, unspecified
9.2
13.1
28
24
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.6
13.1
60
132
SPA47
NOMESCO Finland
Precision impression for denture
62.9
13.0
16
*
DAB00
NOMESCO Finland
Excision of lesion of auricle
4.9
13.0
44
72
U29
ICPC
Urinary symptom/complaint other
4.6
13.0
46
79
K03.88
ICD-10 Finland
Other specified diseases of hard tissues of teeth
24.9
13.0
19
6
R29
ICPC
Respiratory symptom/complaint other
4.0
13.0
54
109
B02
ICD-10 Finland
Zoster [herpes zoster]
5.4
13.0
40
59
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
3.1
13.0
74
192
L02AE02
ATC
leuprorelin; implant, parenteral
2.1
12.9
161
637
M01AH01
ATC
celecoxib; oral (coxibs)
1.9
12.9
215
950
S26
ICPC
Fear of cancer of skin
19.7
12.8
20
8
114
Kela drug reimbursment
Glaucoma
1.8
12.8
238
1091
A06AC51
ATC
ispaghula, combinations; systemic
3.3
12.7
66
160
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
3.8
12.7
55
115
J01FF01
ATC
clindamycin; systemic
1.7
12.7
285
1385
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
0.1
12.7
*
339
G47.3
ICD-10 Finland
Sleep apnoea
2.6
12.7
98
306
S70.0
ICD-10 Finland
Contusion of hip
2.5
12.6
101
321
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.7
12.6
57
124
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
8.5
12.5
28
26
H02AB06
ATC
prednisolone; systemic
1.5
12.5
658
3950
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
11.1
12.4
24
17
K04.09
ICD-10 Finland
Pulpit UNS
17.5
12.4
20
9
A23
ICPC
Risk factor NOS
3.4
12.3
61
143
A05
ICPC
Feeling ill
3.9
12.3
52
107
E000001
ATC
NA
1.7
12.2
278
1357
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
4.6
12.2
43
74
-59
ICPC
Other therap proced/minor surg NEC
5.3
12.2
38
57
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.4
12.2
60
140
SGA05
NOMESCO Finland
Very demanding and lengthy opening and dilatation of root canal of tooth
59.0
12.1
15
*
K99
ICPC
Cardiovascular disease other
3.6
12.1
56
124
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.6
12.1
56
124
K28
ICPC
Limited function/disability (K)
3.7
12.1
54
116
T93
ICPC
Lipid disorder
6.0
12.1
34
45
F13
ICPC
Eye sensation abnormal
10.5
12.1
24
18
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
3.0
12.0
70
185
TKC20
NOMESCO Finland
Catheterisation of bladder
1.9
11.9
191
830
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
2.9
11.9
76
211
S93.4
ICD-10 Finland
Sprain and strain of ankle
4.5
11.9
43
76
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.0
11.8
48
95
S02
ICPC
Pruritus
4.9
11.8
39
63
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
11.7
764
4770
S10
ICPC
Boil/carbuncle
4.7
11.7
41
70
S43.4
ICD-10 Finland
Sprain and strain of shoulder joint
7.2
11.7
29
32
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.9
11.7
49
100
ACC51
NOMESCO Finland
Release of median nerve
3.6
11.7
54
120
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.8
11.7
79
229
N04BC05
ATC
pramipexole; oral
2.4
11.7
104
353
M53.1
ICD-10 Finland
Cervicobrachial syndrome
3.9
11.6
49
101
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.9
11.5
170
718
D06
ICPC
Abdominal pain localized other
4.0
11.5
47
94
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.8
11.5
198
884
F05
ICPC
Visual disturbance other
6.0
11.5
32
42
D06BX02
ATC
ingenol mebutate; topical
6.3
11.5
31
39
B35.3
ICD-10 Finland
Tinea pedis
4.4
11.4
42
76
SPAT1152
SPAT
Removal of foreign body from under the skin
7.6
11.4
27
28
H35.38
ICD-10 Finland
Preretinal fibrosis of the macula
4.6
11.4
40
69
PLAK1
NOMESCO Finland
NA
+∞
11.3
12
*
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
11.3
190
841
WYA20
NOMESCO Finland
Home visit
2.8
11.3
74
211
B03BA03
ATC
hydroxocobalamin; parenteral
1.9
11.3
177
763
W19
ICD-10 Finland
Unspecified fall
1.9
11.3
168
713
N05AX08
ATC
risperidone; systemic
1.7
11.3
241
1155
I49.5
ICD-10 Finland
Sick sinus syndrome
2.2
11.2
114
413
SPA55
NOMESCO Finland
Determination of bite and dental arch location
102.0
11.2
13
*
Z09
ICPC
Legal problem
102.0
11.2
13
*
K40
ICD-10 Finland
Inguinal hernia
4.0
11.2
45
89
U13
ICPC
Bladder symptom/complaint other
4.0
11.2
45
89
M10.9
ICD-10 Finland
Gout, unspecified
2.2
11.1
122
455
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.4
11.1
54
125
R50.9
ICD-10 Finland
Fever, unspecified
1.7
11.1
228
1076
S61.9
ICD-10 Finland
Open wound of wrist and hand, part unspecified
5.1
11.0
35
54
N06AX21
ATC
duloxetine; oral
2.9
11.0
71
199
M02AA10
ATC
ketoprofen; topical
1.8
11.0
206
946
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
2.8
11.0
72
206
4402A
ICD-9 Finland
Atherosclerosis, Of native arteries of the extremities
0.2
11.0
10
405
U01
ICPC
Dysuria/painful urination
4.4
10.9
40
72
A48
ICPC
General and Unspecified, Clarification/discussion RFE/demand
3.4
10.9
54
127
B01AF03
ATC
edoxaban; oral
5.6
10.9
32
45
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
5.6
10.9
32
45
T92
ICPC
Gout
5.6
10.9
32
45
XCH00
NOMESCO Finland
Eye pressure measurement
3.5
10.9
52
119
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.7
10.9
76
226
H91.9
ICD-10 Finland
Hearing loss, unspecified
2.8
10.9
71
202
SPAT1016
SPAT
Examination of vision
3.3
10.9
56
136
SPAT1059
SPAT
Spirometry at the office
3.8
10.9
47
99
I48.1
ICD-10 Finland
Persistent atrial fibrillation
5.0
10.9
35
55
SPAT1370
SPAT
Other health check-up
4.7
10.8
37
62
C01AA05
ATC
digoxin; systemic
0.6
10.8
208
2477
R09
ICPC
Sinus symptom/complaint
15.7
10.8
18
9
SPF02
NOMESCO Finland
Impression for dental prosthesis repair, restricted
29.4
10.8
15
*
SPAT1240
SPAT
Therapeutic discussion
4.6
10.8
38
66
N02AC04
ATC
dextropropoxyphene; oral
0.4
10.7
36
745
K30
ICD-10 Finland
Functional dyspepsia
2.7
10.7
74
218
WX140
NOMESCO Finland
Parabulbar anesthesy
2.8
10.7
69
194
-34
ICPC
Blood test
3.8
10.6
46
97
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.3
10.6
53
126
XF600
NOMESCO Finland
Bloodpressure measurement
2.2
10.6
107
386
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.8
10.6
194
883
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.4
10.6
51
118
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
2.6
10.6
77
235
HAHOM
NOMESCO Finland
NA
36.6
10.6
14
*
M75
ICD-10 Finland
Shoulder lesions
4.9
10.5
35
57
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
6.7
10.5
27
32
H28
ICPC
Limited function/disability (H)
6.3
10.5
28
35
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.0
10.4
144
591
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
2.8
10.4
68
193
K10.3
ICD-10 Finland
Alveolitis of jaws
16.7
10.4
17
8
N20.1
ICD-10 Finland
Calculus of ureter
3.3
10.4
54
132
M03BC51
ATC
orphenadrine, combinations; systemic
1.8
10.4
196
900
R4120
NOMESCO Finland
Occupational therapy
2.8
10.4
69
199
WX290
SPAT
NA
+∞
10.4
11
*
WX402
NOMESCO Finland
General anaesthesia
2.8
10.4
68
194
R95
ICPC
Chron obstructive pulmonary disease
3.3
10.4
52
124
SPA60
NOMESCO Finland
Fitting of intermediary dental prosthesis structures, 1 to 3 units
50.9
10.4
13
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
3.2
10.4
55
137
ZXC15
NOMESCO Finland
Use of photodynamic technique
4.4
10.3
38
69
D07AD01
ATC
clobetasol; topical
2.1
10.3
127
500
SPF11
NOMESCO Finland
Fitting of dental prosthesis
94.1
10.3
12
*
K00.09
ICD-10 Finland
Lack of teeth due to lack of dental development UNS
23.6
10.2
15
5
M47.9
ICD-10 Finland
Spondylosis, unspecified
3.4
10.2
49
113
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
2.7
10.2
72
216
F03
ICPC
Eye discharge
3.6
10.2
47
105
WX199
NOMESCO Finland
Other local analgesia
4.5
10.2
36
63
R07.0
ICD-10 Finland
Pain in throat
5.3
10.2
31
46
K74
ICPC
Ischaemic heart dis with angina
5.3
10.2
31
46
SPAT1070
SPAT
Doppler ultrasound examination of blood flow in arteries of lower extremity
5.3
10.2
31
46
AN4
HP
Balloon angioplasty and drug eluding stent
3.0
10.1
59
157
-64
ICPC
Encounter/prob initiated by provider
7.0
10.1
25
28
H26.9
ICD-10 Finland
Cataract, unspecified
7.0
10.1
25
28
L60.0
ICD-10 Finland
Ingrowing nail
4.2
10.1
38
71
K05.0
ICD-10 Finland
Acute gingivitis
14.9
10.0
17
9
SPA40
NOMESCO Finland
Precision impression for dental prosthesis
14.9
10.0
17
9
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
14.9
10.0
17
9
L09
ICPC
Arm symptom/complaint
4.7
10.0
34
57
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
4.7
10.0
34
57
I83
ICD-10 Finland
Varicose veins of lower extremities
7.9
10.0
23
23
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.4
10.0
85
283
SPAT1359
SPAT
Use of symptom diary
7.3
9.9
24
26
D18
ICPC
Change in faeces/bowel movements
7.3
9.9
24
26
S09
ICPC
Infected finger/toe
5.0
9.9
32
51
I44.7
ICD-10 Finland
Left bundle-branch block, unspecified
4.7
9.8
33
55
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
3.1
9.8
55
142
K87
ICPC
Hypertension complicated
4.0
9.8
39
77
B80
ICPC
Iron deficiency anaemia
5.3
9.8
30
45
I20
ICD-10 Finland
Angina pectoris
3.4
9.8
47
109
I49.3
ICD-10 Finland
Ventricular premature depolarization
2.8
9.7
64
183
NFB50
NOMESCO Finland
Primary total prosthetic replacement of hip joint using cement
2.3
9.7
91
316
U08
ICPC
Urinary retention
3.6
9.7
44
97
WF002
NOMESCO Finland
Radical radiotherapy
4.9
9.7
32
52
K05.08
ICD-10 Finland
Another acute gingivitis
34.0
9.7
13
*
F06.7
ICD-10 Finland
Mild cognitive disorder
2.8
9.7
61
171
L81
ICPC
Injury musculoskeletal NOS
5.9
9.7
27
36
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
5.9
9.7
27
36
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
6.2
9.7
26
33
DHB00
NOMESCO Finland
Excision of lesion of external nose
5.0
9.7
31
49
4148X
ICD-9 Finland
Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]
0.1
9.6
*
277
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
3.9
9.6
40
82
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.6
9.6
44
98
J31.0
ICD-10 Finland
Chronic rhinitis
3.8
9.6
41
86
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
3.7
9.6
42
90
I21.9
ICD-10 Finland
Acute myocardial infarction, unspecified
0.4
9.6
34
685
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.7
9.5
206
989
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
3.6
9.5
43
95
R13
ICD-10 Finland
Dysphagia
2.3
9.5
90
316
ND1AA
NOMESCO Finland
Wrist X-ray examination
3.7
9.5
42
91
R39.1
ICD-10 Finland
Other difficulties with micturition
3.0
9.5
55
146
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
1.9
9.5
135
563
D02AE01
ATC
carbamide; topical
2.6
9.5
71
221
SPF03
NOMESCO Finland
Impression for dental prosthesis repair, demanding
47.0
9.5
12
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.5
9.5
74
236
SAAPA
NOMESCO Finland
NA
+∞
9.5
10
*
R20.2
ICD-10 Finland
Paraesthesia of skin
4.1
9.4
37
72
R5599
NOMESCO Finland
Other rehabilitation service
4.1
9.4
37
72
N06AX26
ATC
vortioxetine; oral
5.0
9.4
30
47
S02.5
ICD-10 Finland
Fracture of tooth
22.0
9.4
14
5
A62
ICPC
General and Unspecified, Administrative procedure
4.7
9.4
32
54
-48
ICPC
Clarification/discussion RFE/demand
5.2
9.4
29
44
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
0.5
9.4
78
1159
S17
ICPC
Abrasion/scratch/blister
4.5
9.3
33
58
SPAT1276
SPAT
Outlining of treatment with patient or their family members
3.2
9.3
50
126
KH1AD
NOMESCO Finland
CT of urinary organs
5.4
9.3
28
41
TQW40
NOMESCO Finland
Remowal of suture of skin
3.1
9.3
52
133
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
1.9
9.3
139
589
SPAT1050
SPAT
Extensive neurological examination
3.9
9.3
38
77
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.7
9.3
210
1020
L02BB04
ATC
enzalutamide; oral
12.2
9.3
17
11
G04BD11
ATC
fesoterodine; oral
3.2
9.3
48
118
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.6
9.3
42
93
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
2.9
9.3
58
162
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
6.2
9.3
25
32
C09CA03
ATC
valsartan; oral
2.1
9.2
105
402
ZXC20
NOMESCO Finland
Use of chemical agents
3.2
9.2
49
123
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.0
9.2
127
524
J01MA12
ATC
levofloxacin; systemic
1.5
9.2
327
1785
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
7.9
9.2
21
21
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
7.9
9.2
21
21
PD5BD
NOMESCO Finland
Extensive CT of aorta
3.6
9.2
41
90
SPF20
NOMESCO Finland
Temporary soling for filling
9.3
9.2
19
16
S00.0
ICD-10 Finland
Superficial injury of scalp
3.2
9.2
47
115
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
4.3
9.1
34
63
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.0
9.1
52
136
S76
ICPC
Skin infection other
3.1
9.1
49
124
U14
ICPC
Kidney symptom/complaint
5.5
9.1
27
39
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
3.1
9.1
51
131
H82
ICPC
Vertiginous syndrome
7.2
9.1
22
24
NG2AA
NOMESCO Finland
Patella X-ray examination
7.2
9.1
22
24
CBB11
NOMESCO Finland
Resection of lax skin in upper eyelid
25.5
9.1
13
*
H40.0
ICD-10 Finland
Glaucoma suspect
2.4
9.1
77
256
A02BD03
ATC
lansoprazole, amoxicillin and metronidazole; systemic
2.0
9.1
120
487
SPAT1246
SPAT
Screening of depression or other psychiatric problem
5.0
9.0
29
46
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.0
9.0
29
46
S61.8
ICD-10 Finland
Open wound of other parts of wrist and hand
4.6
9.0
31
53
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
2.0
9.0
122
500
Y94.0
ICD-10 Finland
Accident at home
3.4
9.0
44
104
L75
ICPC
Fracture: femur
3.5
8.9
42
96
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
3.9
8.9
37
76
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
3.9
8.9
37
76
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
3.0
8.9
51
134
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
5.5
8.9
26
37
N06AB10
ATC
escitalopram; oral
1.9
8.9
143
623
WX872
NOMESCO Finland
Intensive care
3.3
8.9
44
105
I48.2
ICD-10 Finland
Chronic atrial fibrillation
3.3
8.9
44
105
P29
ICPC
Psychological sympt/compl other
5.8
8.9
25
34
H81.3
ICD-10 Finland
Other peripheral vertigo
3.9
8.8
36
73
-1
SPAT
NA
5.0
8.8
28
44
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.9
8.8
141
615
N05AD03
ATC
melperone; systemic
0.2
8.8
7
308
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
2.8
8.8
55
154
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.7
8.8
62
186
Z00.8
ICD-10 Finland
Other general examinations
2.5
8.8
69
221
J02AC01
ATC
fluconazole; systemic
1.6
8.8
244
1255
J01CF05
ATC
flucloxacillin; systemic
4.1
8.8
34
66
J02AC02
ATC
itraconazole; systemic
1.9
8.7
140
609
D07AB08
ATC
desonide; topical
1.8
8.7
144
635
N05CF02
ATC
zolpidem; oral
1.9
8.7
136
586
A13
ICPC
Concern/fear medical treatment
7.2
8.7
21
23
F01
ICPC
Eye pain
7.2
8.7
21
23
CS494
NOMESCO Finland
Other visual field testing
7.2
8.7
21
23
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
3.8
8.7
37
78
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
4.3
8.7
32
59
TKC22
NOMESCO Finland
Catheterisation instruction
4.3
8.7
32
59
A02BC04
ATC
rabeprazole; oral
2.9
8.7
54
150
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
2.0
8.7
115
467
A50
ICPC
General and Unspecified, Medication/prescr/renewal
3.3
8.7
44
107
N06DA03
ATC
rivastigmine; oral, transdermal
1.8
8.7
147
654
163
Kela drug reimbursment
Abiraterone and enzalutamide
6.7
8.7
22
26
Z08
ICPC
Social welfare problem
6.7
8.7
22
26
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
4.6
8.7
30
52
D07AA02
ATC
hydrocortisone; topical
1.7
8.7
185
883
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
0.1
8.6
*
216
S82.6
ICD-10 Finland
Fracture of lateral malleolus
2.8
8.6
55
156
XF402
NOMESCO Finland
ECG with work load test
2.1
8.6
100
384
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.1
8.6
96
364
K02.9
ICD-10 Finland
Dental caries, unspecified
8.3
8.6
19
18
S01EE03
ATC
bimatoprost; ophthalmic
3.2
8.6
45
112
D89
ICPC
Inguinal hernia
5.1
8.6
27
42
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.6
8.6
64
197
SPA50
NOMESCO Finland
Determination of bite and dental arch location
43.1
8.6
11
*
Y16
ICPC
Breast symptom/complaint male
43.1
8.6
11
*
L03.9
ICD-10 Finland
Cellulitis, unspecified
4.7
8.6
29
49
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
2.2
8.5
88
321
AA1XD
NOMESCO Finland
Other special CT of head and brain
15.7
8.5
14
7
PLAK2
NOMESCO Finland
NA
+∞
8.5
9
*
L84
ICD-10 Finland
Corns and callosities
4.0
8.5
34
68
H25.0
ICD-10 Finland
Senile incipient cataract
1.9
8.5
123
516
L88
ICPC
Rheumatoid/seropositive arthritis
5.7
8.5
24
33
H01.0
ICD-10 Finland
Blepharitis
3.6
8.5
38
84
SPAT1147
SPAT
Destruction of skin lesion with external methods
6.4
8.5
22
27
K03.11
ICD-10 Finland
Abrasion dentifrice of teeth
78.4
8.5
10
*
SPC36
NOMESCO Finland
Direct fibre-reinforced dental bridge
78.4
8.5
10
*
JONO
NOMESCO Finland
NA
78.4
8.5
10
*
SPA45
NOMESCO Finland
Precision impression for dental prosthesis, demanding
78.4
8.5
10
*
SPE02
NOMESCO Finland
Metal-framed partial denture
78.4
8.5
10
*
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
4.1
8.4
32
61
M13.9
ICD-10 Finland
Arthritis, unspecified
2.6
8.4
63
196
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.7
8.4
168
787
-30
ICPC
Medical examin/health eval complete
4.4
8.4
30
54
D01AE15
ATC
terbinafine; topical
2.0
8.4
103
408
R51.81
ICD-10 Finland
Facial pain NOS
9.5
8.3
17
14
WVA30
SPAT
NA
7.2
8.3
20
22
B07.9
ICD-10 Finland
Verruca simplex
5.6
8.3
24
34
TDA90
NOMESCO Finland
Removal wax from ear
4.8
8.3
27
44
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
1.8
8.3
133
581
S01EC54
ATC
brinzolamide, combinations; ophthalmic
6.6
8.3
21
25
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.5
8.2
65
208
S77
ICPC
Malignant neoplasm of skin
5.0
8.2
26
41
S01.50
ICD-10 Finland
Open wound in oral cavity
8.3
8.2
18
17
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
4.2
8.2
31
59
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.6
8.2
60
186
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
3.4
8.2
39
91
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
0.3
8.2
13
380
K04.6
ICD-10 Finland
Periapical abscess with sinus
17.0
8.1
13
6
E000007
ATC
NA
3.0
8.1
46
120
SPAT1284
SPAT
Extensive health certificate
3.5
8.1
38
87
N18
ICD-10 Finland
Chronic kidney disease
3.9
8.1
33
67
G45.4
ICD-10 Finland
Transient global amnesia
4.7
8.1
27
45
Z43.5
ICD-10 Finland
Attention to cystostomy
4.7
8.1
27
45
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
3.8
8.1
34
71
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
2.1
8.1
94
362
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.6
8.1
61
190
N05CD07
ATC
temazepam; oral
0.6
8.1
203
2295
ZX198
NOMESCO Finland
Other local administration
5.7
8.1
23
32
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
2.8
8.1
51
144
ZXH06
SPAT
NA
8.9
8.1
17
15
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.2
8.1
78
278
Y85
ICPC
Benign prostatic hypertrophy
4.5
8.1
28
49
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
6.4
8.1
21
26
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
2.2
8.0
83
305
S20.2
ICD-10 Finland
Contusion of thorax
2.4
8.0
68
228
WYA30
SPAT
NA
28.8
8.0
11
*
K03.80
ICD-10 Finland
Irradiated enamel
28.8
8.0
11
*
D64.8
ICD-10 Finland
Other specified anaemias
3.1
8.0
43
110
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
2.1
8.0
91
349
SBA00
NOMESCO Finland
Microbiological examinations
7.9
8.0
18
18
L92
ICPC
Shoulder syndrome
9.7
7.9
16
13
A10AA02
ATC
NA
0.3
7.9
22
495
C09DA01
ATC
losartan and diuretics; oral
2.0
7.9
105
426
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
3.4
7.9
37
85
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
3.9
7.9
32
65
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
3.9
7.9
32
65
J01MA14
ATC
moxifloxacin; systemic
1.9
7.9
124
537
R03.0
ICD-10 Finland
Elevated blood-pressure reading, without diagnosis of hypertension
5.8
7.9
22
30
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
5.8
7.9
22
30
M72.0
ICD-10 Finland
Palmar fascial fibromatosis [Dupuytren]
2.4
7.9
64
210
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
0.2
7.8
7
288
K01
ICPC
Heart pain
4.9
7.8
25
40
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.2
7.8
83
307
H93.1
ICD-10 Finland
Tinnitus
3.4
7.8
37
86
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
2.5
7.8
60
191
K43
ICPC
Cardiovascular, Other diagnostic procedure
5.1
7.8
24
37
M15.8
ICD-10 Finland
Other polyarthrosis
12.2
7.8
14
9
A10AE04
ATC
insulin glargine; parenteral
1.9
7.8
123
535
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
2.8
7.7
49
139
K59.1
ICD-10 Finland
Functional diarrhoea
2.4
7.7
63
207
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
7.4
7.7
18
19
J30.0
ICD-10 Finland
Vasomotor rhinitis
4.4
7.7
27
48
L10
ICPC
Elbow symptom/complaint
4.4
7.7
27
48
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.8
7.7
25
41
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
2.7
7.7
52
153
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
2.3
7.7
68
233
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
0.2
7.7
6
267
TKE00
NOMESCO Finland
Needle biopsy of prostate
1.8
7.7
140
639
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
4.2
7.6
28
52
N87
ICPC
Parkinsonism
4.2
7.6
28
52
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
3.3
7.6
37
88
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
4.1
7.6
29
56
K59.0
ICD-10 Finland
Constipation
1.8
7.6
122
534
C10AA04
ATC
fluvastatin; oral
1.7
7.6
172
837
EB1SA
SPAT
NA
+∞
7.6
8
*
SPAT1283
SPAT
Restricted health certificate
3.2
7.6
39
97
SPC30
NOMESCO Finland
Tooth bridge attacment with resins
70.5
7.6
9
*
K03.18
ICD-10 Finland
Other abrasion of the teeth
70.5
7.6
9
*
D10
ICPC
Vomiting
3.7
7.6
32
68
R07.2
ICD-10 Finland
Precordial pain
4.3
7.5
27
49
S90.0
ICD-10 Finland
Contusion of ankle
9.8
7.5
15
12
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
3.2
7.5
38
93
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
3.0
7.5
43
114
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
3.1
7.5
40
102
CBB30
NOMESCO Finland
Excision of lesion of eyelid
3.1
7.5
42
109
AA1
HP
Conventional CABG
2.7
7.5
51
151
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
2.3
7.5
69
241
XKC03
NOMESCO Finland
Water cystometry
4.5
7.5
26
46
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.4
7.5
409
2426
DAB10
NOMESCO Finland
Partial excision of auricle
6.1
7.5
20
26
R09.3
ICD-10 Finland
Abnormal sputum
6.1
7.5
20
26
K60
ICPC
Cardiovascular, Result test/procedure
6.1
7.5
20
26
-55
ICPC
Local injection/infiltration
6.1
7.5
20
26
I84
ICD-10 Finland
Hemorrhoids
4.8
7.5
24
39
AS4
HP
Physiological pacemaker insertion DDD (R)
2.9
7.5
44
120
M71.2
ICD-10 Finland
Synovial cyst of popliteal space [Baker]
3.9
7.5
30
61
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.1
7.4
81
306
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.2
7.4
71
252
B01AX06
ATC
[U] rivaroxaban; oral
4.3
7.4
27
50
GD1AD
NOMESCO Finland
Thorax CT examination
3.3
7.4
37
90
S01EC04
ATC
brinzolamide; ophthalmic
2.3
7.4
66
227
WYA00
NOMESCO Finland
Screening and health check-up
8.4
7.4
16
15
WX111
NOMESCO Finland
Local infiltration anesthesia
8.4
7.4
16
15
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.1
7.4
82
310
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.3
7.3
65
221
G30.8
ICD-10 Finland
Other Alzheimer disease
2.0
7.3
93
373
SPAT1202
SPAT
Intra-articular injection
3.4
7.3
34
78
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
5.2
7.3
22
33
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.5
7.3
33
74
J01FA09
ATC
clarithromycin; systemic
1.6
7.3
204
1047
S14
ICPC
Burn/scald
4.4
7.3
26
47
R1260
NOMESCO Finland
Evaluation of communicative skills
3.2
7.3
37
91
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
4.7
7.3
24
40
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
2.3
7.3
68
239
C01DA14
ATC
isosorbide mononitrate; oral
1.3
7.3
602
3825
SPAT1244
SPAT
Occupational therapy
5.5
7.3
21
30
TQW11
NOMESCO Finland
Vacuum treatment of wound
5.5
7.3
21
30
XF400
NOMESCO Finland
ECG with 12 standard connections
1.4
7.3
342
1971
G30
ICD-10 Finland
Alzheimer disease
2.5
7.3
56
177
K24
ICPC
Fear of heart disease
5.8
7.3
20
27
N02AX02
ATC
tramadol; systemic, rectal
1.4
7.3
555
3481
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
2.4
7.3
62
208
M70.2
ICD-10 Finland
Olecranon bursitis
3.3
7.3
35
83
AN3
HP
Balloon angioplasty and metallic stent
2.1
7.2
77
287
1LA05
NOMESCO Finland
NA
9.1
7.2
15
13
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.0
7.2
41
108
L02BX02
ATC
degarelix; parenteral
4.5
7.2
25
44
-43
ICPC
Other diagnostic procedure
4.9
7.2
23
37
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.9
7.2
106
450
D23.2
ICD-10 Finland
Benign neoplasm: Skin of ear and external auricular canal
3.9
7.2
29
59
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
2.8
7.2
45
126
R03DC03
ATC
montelukast; oral
1.9
7.2
100
417
H02.1
ICD-10 Finland
Ectropion of eyelid
2.6
7.2
52
159
WVA20
NOMESCO Finland
Medicine administration
4.6
7.1
24
41
SPF31
NOMESCO Finland
Denture relining/rebasing
26.1
7.1
10
*
TQW40
SPAT
NA
7.9
7.1
16
16
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.5
7.1
261
1427
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
3.9
7.1
28
56
WF004
NOMESCO Finland
Palliative radiotherapy
3.7
7.1
30
64
4289X
ICD-9 Finland
Heart failure, unspecified
0.0
7.1
*
164
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
3.3
7.1
35
85
J06
ICD-10 Finland
Acute upper respiratory infections of multiple and unspecified sites
6.4
7.0
18
22
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
6.4
7.0
18
22
130
Kela drug reimbursment
Malignant tumour
0.5
7.0
49
772
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.2
7.0
26
49
H02.3
ICD-10 Finland
Blepharochalasis
2.5
7.0
53
168
ECA10
NOMESCO Finland
Incision of gingiva
11.3
7.0
13
9
S02.52
ICD-10 Finland
Tooth fracture to pulp
17.2
7.0
11
5
D25
ICPC
Abdominal distension
17.2
7.0
11
5
-2
ICPC
NA
3.5
7.0
32
73
A31
ICPC
General and Unspecified, Medical examin/health eval partial
3.8
7.0
29
61
L60.1
ICD-10 Finland
Onycholysis
13.4
7.0
12
7
S69.9
ICD-10 Finland
Unspecified injury of wrist and hand
8.4
7.0
15
14
R04
ICPC
Breathing problem other
4.1
6.9
26
50
R06AE09
ATC
levocetirizine; oral
2.2
6.9
70
256
ND1BA
NOMESCO Finland
Wrist extensive X-ray examination
5.4
6.9
20
29
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
7.4
6.9
16
17
A30
ICPC
General and Unspecified, Medical examin/health eval complete
7.4
6.9
16
17
S61.0
ICD-10 Finland
Open wound of finger(s) without damage to nail
2.8
6.9
44
126
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
0.0
6.9
*
161
S01.8
ICD-10 Finland
Open wound of other parts of head
3.9
6.9
27
54
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
3.8
6.9
28
58
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
3.8
6.9
28
58
L95
ICPC
Osteoporosis
5.7
6.9
19
26
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
35.2
6.9
9
*
SPE05
NOMESCO Finland
Demanding fitting and preparation of metal structure partial teeth prosthesis
35.2
6.9
9
*
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
6.7
6.9
17
20
TDA90
SPAT
NA
6.2
6.8
18
23
I71.3
ICD-10 Finland
Abdominal aortic aneurysm, ruptured
0.2
6.8
5
232
1221
FHL
Arthroscopy and meniscus surgery
2.7
6.8
47
140
S52.5
ICD-10 Finland
Fracture of lower end of radius
2.0
6.8
83
328
R01AD01
ATC
beclometasone; nasal
1.7
6.8
129
594
D91
ICPC
Abdominal hernia other
9.2
6.8
14
12
SPAT1257
SPAT
Teaching of medicine inhalation technique
3.1
6.8
36
92
4100X
ICD-9 Finland
Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]
0.5
6.8
48
750
N30.9
ICD-10 Finland
Cystitis, unspecified
1.9
6.8
102
436
S99
ICPC
Skin disease other
4.5
6.8
23
40
L18
ICPC
Muscle pain
4.5
6.8
23
40
S70
ICPC
Herpes zoster
4.5
6.8
23
40
4912A
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]
0.1
6.8
*
177
SPAT1210
SPAT
Application of cast or individual aid
3.9
6.8
27
55
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
3.9
6.8
27
55
SPAT1088
SPAT
Blood transfusion
7.9
6.7
15
15
K13.78
ICD-10 Finland
Other change in the oral mucosa
7.9
6.7
15
15
R23
ICPC
Voice symptom/complaint
10.2
6.7
13
10
Z2446
NOMESCO Finland
Social worker
1.9
6.7
98
416
R25.2
ICD-10 Finland
Cramp and spasm
4.7
6.7
22
37
H40.9
ICD-10 Finland
Glaucoma, unspecified
2.9
6.7
39
106
E000006
ATC
NA
2.0
6.7
86
348
N18
ICPC
Paralysis/weakness
3.3
6.7
32
76
4120X
ICD-9 Finland
Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]
0.4
6.7
25
493
M94.0
ICD-10 Finland
Chondrocostal junction syndrome [Tietze]
7.0
6.7
16
18
K03.2
ICD-10 Finland
Erosion of teeth
62.7
6.7
8
*
KHV
NOMESCO Finland
NA
62.7
6.7
8
*
M10.0
ICD-10 Finland
Idiopathic gout
2.4
6.6
53
173
SPAT1377
SPAT
Polysomnography
19.6
6.6
10
*
K05.4
ICD-10 Finland
Periodontosis
19.6
6.6
10
*
R5110
SPAT
NA
3.6
6.6
29
64
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
0.3
6.6
19
419
SPAT1138
SPAT
Guidance concerning bowel function
3.2
6.6
34
85
PLAK3
NOMESCO Finland
NA
+∞
6.6
7
*
K03.28
ICD-10 Finland
Other erosion of teeth
+∞
6.6
7
*
K02.3
ICD-10 Finland
Arrested dental caries
+∞
6.6
7
*
E03
ICD-10 Finland
Other hypothyroidism
3.3
6.6
32
77
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
5.1
6.6
20
31
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
4.6
6.5
22
38
ZA1.0
ICD-10 Finland
Shoulder region
4.6
6.5
22
38
S01
ICD-10 Finland
Open wound of head
3.4
6.5
30
69
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
0.1
6.5
*
190
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.7
6.5
133
628
-1
ICD-10 Finland
NA
5.3
6.5
19
28
N30
ICD-10 Finland
Cystitis
2.3
6.5
58
201
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.6
6.5
45
135
JN4CD
NOMESCO Finland
Very extensive body CT
2.7
6.5
42
122
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
4.3
6.5
23
42
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
7.4
6.5
15
16
TPX22
NOMESCO Finland
Intravenous arterial thrombolysis
7.4
6.5
15
16
NF1DA
NOMESCO Finland
X-ray of hips
4.1
6.4
24
46
B01AB04
ATC
dalteparin; parenteral
2.1
6.4
69
259
F02
ICPC
Red eye
3.8
6.4
26
54
H43.8
ICD-10 Finland
Other disorders of vitreous body
2.9
6.4
38
105
M54.8
ICD-10 Finland
Other dorsalgia
3.7
6.4
27
58
SPAT1266
SPAT
Separate instruction to prepare for procedure
3.7
6.4
27
58
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
4.9
6.4
20
32
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.8
6.4
108
483
C10AX09
ATC
ezetimibe; oral
2.6
6.4
45
138
A06
ICPC
Fainting/syncope
4.2
6.3
23
43
K88
ICPC
Postural hypotension
4.2
6.3
23
43
L02BB03
ATC
bicalutamide; oral
1.7
6.3
118
543
T79.3
ICD-10 Finland
Post-traumatic wound infection, not elsewhere classified
5.2
6.3
19
29
R41.0
ICD-10 Finland
Disorientation, unspecified
1.8
6.3
100
435
PH1AC
NOMESCO Finland
Flebography of over extremity with X-ray
4.0
6.3
24
47
H40
ICD-10 Finland
Glaucoma
4.0
6.3
24
47
Z29.8
ICD-10 Finland
Other specified prophylactic measures
7.8
6.3
14
14
A10BK01
ATC
dapagliflozin; oral
7.8
6.3
14
14
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
2.6
6.3
44
133
SGB00
NOMESCO Finland
Partial removal of pulpa of tooth
23.5
6.3
9
*
L87
ICPC
Bursitis/tendinitis/synovitis NOS
23.5
6.3
9
*
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.1
6.3
66
246
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.7
6.3
42
125
U07.2
ICD-10 Finland
COVID-19, virus not identified
3.5
6.3
28
63
R00.2
ICD-10 Finland
Palpitations
2.8
6.3
40
114
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
3.7
6.3
26
55
Z11
ICPC
Compliance/being ill problem
5.8
6.3
17
23
NJ3NA
NOMESCO Finland
Measurement of difference in extremity lengty with X-ray
5.8
6.3
17
23
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
3.2
6.3
31
76
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.2
6.3
31
76
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
6.3
6.2
16
20
S01BC05
ATC
ketorolac; ophthalmic
1.6
6.2
148
731
K03
ICPC
Cardiovascular pain NOS
12.3
6.2
11
7
SDC30
NOMESCO Finland
Strong parodontological fixation of 2-3 teeth
15.7
6.2
10
5
F27
ICPC
Fear of eye disease
15.7
6.2
10
5
M05BA04
ATC
alendronic acid; oral
1.6
6.2
152
756
N06DA04
ATC
galantamine; oral
2.0
6.2
80
324
W10
ICD-10 Finland
Fall on and from stairs and steps
2.2
6.2
58
206
Z71.9
ICD-10 Finland
Counselling, unspecified
2.6
6.2
44
136
NC2AA
NOMESCO Finland
Forearm X-ray examination
8.5
6.2
13
12
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.7
6.1
40
117
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
0.3
6.1
15
353
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.2
6.1
22
41
M75.8
ICD-10 Finland
Other shoulder lesions
5.2
6.1
18
27
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
2.1
6.1
65
245
FN1BT
NOMESCO Finland
Extensive endovascular dilatation of coronary (PTCA) arteries
2.3
6.1
52
176
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
2.4
6.1
50
167
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
1.8
6.1
93
402
WX204
NOMESCO Finland
Axillary plexus blockaced
4.6
6.1
20
34
N19
ICPC
Speech disorder
4.0
6.1
23
45
M01AX17
ATC
nimesulide; oral
1.4
6.1
312
1824
S99.9
ICD-10 Finland
Unspecified injury of ankle and foot
7.3
6.1
14
15
K80
ICD-10 Finland
Cholelithiasis
7.3
6.1
14
15
NG4AA
NOMESCO Finland
Lower leg X-ray examination
3.5
6.1
27
61
R15
ICD-10 Finland
Faecal incontinence
3.7
6.1
25
53
Y94.8
ICD-10 Finland
Other leisure activity accident
3.7
6.1
25
53
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
3.1
6.1
31
78
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.7
6.1
39
113
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
6.1
35
95
KBE12
NOMESCO Finland
Transluminal endoscopic extraction of calculus of ureter
6.0
6.0
16
21
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
6.0
6.0
16
21
L02AE04
ATC
triptorelin; parenteral
6.5
6.0
15
18
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
4.3
6.0
21
38
K04.00
ICD-10 Finland
Hyperemia of pulp
9.4
6.0
12
10
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
11490
41081
1.58
315.48
2.3
2.2
mg/l
3.0
3.1
3.76
9760
34894
(40768804) Tissue Pathology biopsy report
17064
66702
1.50
311.67
2.2
2.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
32952
147315
1.53
308.50
19.0
16.5
%
13.7
13.7
1.01
32283
143976
(3023103) Potassium [Moles/volume] in Serum or Plasma
41574
180448
3.08
307.65
18.4
16.0
mmol/l
4.0
4.0
12.76
40643
174712
(3010813) Leukocytes [#/volume] in Blood
44280
199574
6.01
307.65
23.4
19.6
e9/l
6.7
6.8
3.49
43182
192718
(3020564) Creatinine [Moles/volume] in Serum or Plasma
42637
188180
3.54
307.65
18.2
15.7
umol/l
79.9
78.9
6.63
42622
188064
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
37186
156535
2.18
307.65
4.9
4.3
mu/l
2.2
2.1
0.47
34139
142504
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
21309
83905
1.57
307.65
6.9
6.8
mmol/l
1.2
1.2
1.96
17936
70584
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
40598
176395
2.65
307.65
15.9
13.8
mg/l
23.9
25.5
15.79
32955
139262
(3007461) Platelets [#/volume] in Blood
44250
199298
5.92
307.65
23.3
19.6
e9/l
247.2
250.3
18.05
43283
193132
(3013115) Eosinophils [#/volume] in Blood
21672
87644
1.51
307.65
6.2
5.9
e9/l
0.2
0.2
0.13
19049
76069
(3000963) Hemoglobin [Mass/volume] in Blood
44281
199604
6.01
307.65
23.5
19.7
g/l
135.2
135.6
5.56
43762
196116
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
39184
170548
2.27
307.65
4.5
4.0
mmol/l
1.4
1.4
7.70
36179
156915
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
42612
188958
3.43
307.65
10.9
9.5
u/l
26.2
27.0
10.06
41215
181623
(3013826) Glucose [Moles/volume] in Serum or Plasma
24886
100790
1.58
307.65
4.8
4.8
mmol/l
6.7
6.8
8.48
23354
94130
(3019198) Lymphocytes [#/volume] in Blood
21447
87289
1.49
307.65
6.0
5.7
e9/l
1.9
1.9
0.06
18846
76274
(3006315) Basophils [#/volume] in Blood
20984
84978
1.49
307.65
6.0
5.7
e9/l
0.0
0.0
0.12
18144
72910
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
39500
171858
2.34
307.65
4.5
4.1
mmol/l
4.6
4.7
43.85
36686
158871
(3037467) Urinalysis macro (dipstick) panel - Urine
29017
116496
1.76
307.65
4.6
4.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
37242
157571
2.16
307.65
6.0
5.4
mmol/mol
39.9
39.9
0.62
34531
145206
(3013707) Erythrocyte sedimentation rate by Westergren method
30941
123594
1.88
307.65
4.3
3.7
mm/h
12.2
12.6
5.20
28701
113651
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
37911
164846
2.06
307.65
4.0
3.7
mmol/l
1.3
1.3
0.72
34710
150893
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
40282
175235
2.54
307.65
5.0
4.5
mmol/l
2.7
2.8
33.86
37210
161099
(3031040) Bacteria [#/volume] in Urine by Automated count
27898
110426
1.76
307.65
4.9
4.2
e6/l
1159.6
1493.8
0.58
400
1574
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
31959
131789
1.81
307.65
7.6
7.3
u/l
78.8
79.9
2.68
30094
123906
(3032080) INR in Blood by Coagulation assay
17711
69065
1.51
307.65
9.9
9.1
inr
1.3
1.3
0.41
5150
19139
(3044889) 12 lead EKG panel
28462
119445
1.59
307.65
4.0
3.5
—
—
—
0
0
(3035941) MCH [Entitic mass]
44269
199461
5.98
307.65
23.2
19.5
pg
30.3
30.3
8.79
43753
195966
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
21928
88502
1.52
307.65
5.9
6.2
umol/l
11.7
12.0
2.51
20782
83782
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
17811
67800
1.57
307.65
2.1
1.9
pmol/l
95.4
94.4
1.70
9465
35769
(40761511) CBC panel - Blood by Automated count
41712
184755
2.87
307.65
14.9
12.7
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
44274
199526
5.99
307.65
23.3
19.5
e12/l
4.5
4.5
11.39
43174
192702
(3001604) Monocytes [#/volume] in Blood
20875
84557
1.49
307.65
6.0
5.6
e9/l
0.6
0.6
1.12
18035
72622
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
37793
164752
2.03
307.65
14.6
12.8
ml/min/173m2
79.8
80.9
14.56
31602
135192
(3013650) Neutrophils [#/volume] in Blood by Automated count
23884
99023
1.50
307.65
9.1
8.7
e9/l
4.1
4.2
2.77
20889
85818
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
19506
75446
1.57
307.65
6.1
6.2
mmol/l
1.2
1.2
5.61
17698
68021
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
39141
165639
2.50
307.65
4.8
4.2
mmol/l
6.0
5.9
0.57
35791
150409
(3024731) MCV [Entitic volume]
44270
199506
5.98
307.65
23.2
19.5
fl
91.1
90.9
21.61
43755
196002
(3019550) Sodium [Moles/volume] in Serum or Plasma
41487
179819
3.05
307.65
18.3
15.9
mmol/l
139.6
139.6
1.32
40617
174513
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
31206
127790
1.80
307.65
4.0
3.7
pmol/l
14.8
14.8
1.15
28347
115866
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
17211
67774
1.48
299.73
2.3
2.2
nmol/l
78.0
76.5
7.75
15373
60751
(3001122) Ferritin [Mass/volume] in Serum or Plasma
18074
72012
1.47
295.65
2.9
2.8
ug/l
129.6
139.4
3.80
16560
66811
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
19646
79604
1.46
294.82
4.2
3.9
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
10433
36966
1.58
293.99
1.6
1.5
nmol/l
20.2
20.1
0.34
8993
31625
(3019069) Monocytes/100 leukocytes in Blood
19735
80096
1.46
293.06
6.5
6.1
%
8.7
8.7
0.17
18360
75052
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
13371
50222
1.51
289.73
2.2
2.1
u/l
215.5
223.7
0.26
12563
46960
(3006504) Eosinophils/100 leukocytes in Blood
19618
79645
1.46
289.68
6.2
5.9
%
2.9
2.8
0.55
18152
74305
(3035350) Ketones [Presence] in Urine by Test strip
20294
82943
1.46
289.36
3.8
3.5
estimate
0.0
0.0
0.88
3981
14078
(3019309) Folate [Moles/volume] in Red Blood Cells
8947
30650
1.62
289.01
1.8
1.7
nmol/l
1143.0
1167.3
1.51
6783
22859
(3009261) Glucose [Presence] in Urine by Test strip
20526
84126
1.45
287.92
3.8
3.5
estimate
0.0
0.0
0.08
3942
14010
(3002030) Lymphocytes/100 leukocytes in Blood
20205
82589
1.46
287.08
6.3
5.9
%
27.6
27.4
1.47
18661
77131
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
27007
116755
1.45
285.16
3.2
2.9
u/l
49.4
49.9
0.32
25143
108957
(3021601) Nitrite [Presence] in Urine by Test strip
20301
83152
1.45
284.38
5.0
4.8
estimate
0.0
0.0
0.29
4063
14408
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
15321
59451
1.48
282.01
5.1
4.6
ug/l
3.8
3.5
0.25
13739
53121
(3018010) Neutrophils/100 leukocytes in Blood
19891
81251
1.45
281.65
6.1
5.7
%
57.5
57.8
2.54
18474
76102
(3009508) Creatinine [Moles/volume] in Urine
13440
50876
1.50
278.11
3.3
3.1
mmol/l
7.5
7.7
6.09
11326
42367
(3024561) Albumin [Mass/volume] in Serum or Plasma
18369
74230
1.45
271.93
4.9
4.8
g/l
35.4
35.2
4.56
16982
68633
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
13603
51988
1.49
266.00
2.6
2.6
u/l
58.1
59.6
1.10
12593
47960
(3022096) Basophils/100 leukocytes in Blood
18995
77547
1.44
263.55
6.2
5.9
%
0.7
0.7
0.29
17610
72381
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
12661
47950
1.49
256.85
3.2
3.0
ng/l
1605.0
1694.8
1.13
10861
41090
(42870588) Differential panel, method unspecified - Blood
14595
56881
1.46
256.45
5.9
5.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
12807
48684
1.48
254.63
4.1
4.1
ph
7.4
7.4
0.10
2497
8946
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
16376
65335
1.44
253.98
3.9
3.6
ng/l
72.2
74.0
0.02
11453
44579
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
25437
110155
1.41
248.43
3.0
2.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
12542
47684
1.48
247.70
3.3
3.2
mg/l
383.8
400.6
0.14
8067
30302
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
10903
40372
1.50
244.14
1.7
1.6
mmol/l
1.4
1.4
0.47
9242
33753
(3009542) Hematocrit [Volume Fraction] of Blood
35989
166652
1.51
241.39
16.8
14.5
%
39.8
39.8
0.04
25119
123312
(3020682) Albumin/Creatinine [Ratio] in Urine
13118
50680
1.46
236.47
4.0
3.9
mg/mmol
9.2
10.4
1.33
8293
32566
(3018095) Leukocytes [#/volume] in Urine
15073
60368
1.42
219.96
4.0
3.6
e6/l
90.2
112.3
2.29
10961
42543
(3021589) Normoblasts [#/volume] in Blood
18125
75365
1.39
209.84
10.1
9.4
e9/l
0.0
0.0
1.35
14887
61172
(3026008) Bacteria identified in Urine by Culture
12673
49620
1.43
206.46
3.3
3.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
13099
51618
1.42
205.85
3.5
3.2
e6/l
78.5
111.5
1.52
10250
39348
(3000850) Epithelial cells [#/volume] in Urine
9397
34821
1.48
203.40
2.7
2.6
e6/l
4.8
5.5
5.20
8244
30455
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
9015
33168
1.49
201.86
1.3
1.2
u/ml
1.8
1.8
0.11
2366
9123
(36304419) Bacteria [Presence] in Urine
11743
45512
1.43
201.14
3.3
3.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
12044
46934
1.43
200.03
3.4
3.1
e6/l
0.4
0.5
2.82
9284
34931
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
12128
47474
1.42
195.59
4.5
4.0
%
21.9
22.0
0.27
5906
22369
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
9346
34883
1.47
193.67
1.7
1.6
pmol/l
23558804.8
38735723.1
1.75
7717
28718
(3013512) EKG study
12217
48122
1.41
188.85
4.1
3.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
14085
56865
1.39
188.63
3.3
3.5
mmol/l
2.4
2.4
0.37
12156
49533
(3029937) Albumin [Presence] in Urine by Test strip
11229
43597
1.42
187.97
4.3
3.8
estimate
0.0
0.0
0.34
3903
13609
(3000494) Fungus identified in Specimen by Culture
5193
17472
1.59
171.04
1.5
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
7127
25764
1.49
170.05
1.3
1.2
iu/ml
32.0
39.5
2.22
2157
8254
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
7481
27333
1.48
169.38
1.9
1.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
12075
48190
1.39
168.92
4.4
4.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
6707
23991
1.51
168.10
1.3
1.2
u/ml
11.3
12.5
0.61
2477
9761
(3003338) MCHC [Mass/volume]
33245
155196
1.36
159.62
20.3
17.1
g/l
332.5
332.5
0.11
32998
153661
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
8592
32611
1.43
158.30
4.0
3.7
ng/l
386.3
589.5
3.72
6843
25591
(3026493) Urate [Moles/volume] in Serum or Plasma
11356
45344
1.38
155.78
2.7
2.6
umol/l
3054.0
6150.8
13.89
9712
39654
(3015736) pH of Urine
15581
65369
1.34
155.32
3.6
3.3
ph
5.9
5.7
—
9
80
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
13458
55237
1.35
155.08
3.2
3.2
u/l
33.8
34.9
0.40
12724
52278
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
15475
65197
1.33
147.81
4.0
3.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
10726
42866
1.37
144.20
6.8
7.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
5897
21487
1.47
131.88
1.2
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
6170
22707
1.45
131.02
27.7
24.8
inr
1.4
1.4
0.04
844
3183
(3011397) Hemoglobin [Presence] in Urine by Test strip
9701
38704
1.36
129.32
3.8
3.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
13254
55444
1.32
128.24
2.5
2.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
5116
18297
1.49
124.99
2.3
2.4
ug/g
136.0
146.6
1.07
3996
14626
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
8735
34454
1.37
124.33
3.1
2.8
ug/l
0.8
0.8
1.17
5981
21653
(3026782) Osmolality of Urine
8543
33629
1.37
122.92
2.9
2.8
mosm/kgh2o
546.6
553.1
1.50
7270
28792
(3007164) IgA [Mass/volume] in Serum or Plasma
7788
30215
1.39
122.32
1.5
1.4
g/l
2.5
2.5
0.15
4604
19305
(3019150) Specific gravity of Urine by Refractometry
8986
35741
1.36
120.85
4.3
3.9
kg/l
1.0
1.0
2.73
1364
5364
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
10234
41644
1.33
117.98
2.4
2.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
5316
19368
1.46
117.82
4.6
4.2
%
32.5
32.2
1.01
3821
12542
(3045414) Leukocytes [Presence] in Urine
2169
6350
1.79
117.61
2.0
1.8
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
7062
27110
1.40
117.50
2.5
2.5
umol/l
12.8
12.8
0.22
6465
25101
(3022621) pH of Urine by Test strip
3023
9774
1.63
114.55
2.9
2.9
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
9187
36964
1.34
113.52
1.7
1.8
mg/l
1.2
1.3
1.48
6933
28714
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
7409
29027
1.37
107.93
2.9
2.7
e6/l
1.0
1.3
2.18
4326
16291
(3004789) Transferrin [Mass/volume] in Serum or Plasma
6532
25083
1.39
107.44
2.5
2.5
g/l
2.3
2.3
0.35
5980
23190
(3014051) Protein [Presence] in Urine by Test strip
1163
2829
2.13
106.65
2.3
2.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
6914
26866
1.38
105.71
1.5
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
7794
30906
1.35
104.76
3.0
3.1
mmol/l
2.5
2.5
0.81
6724
26948
(3019225) pH of Specimen
4422
15900
1.47
103.86
4.6
4.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
5096
18935
1.43
100.51
1.8
1.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
6094
23436
1.38
98.49
2.6
2.6
%
22.3
22.5
0.48
5115
20139
(3027945) Reticulocytes/100 erythrocytes in Blood
5155
19270
1.42
98.17
2.4
2.5
%
1.7
1.8
1.62
4501
16956
(3007853) Bacteria identified in Skin by Aerobe culture
5254
19713
1.41
97.98
1.8
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
5082
19009
1.42
96.30
1.8
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
6167
23855
1.37
95.98
2.1
2.0
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
3942
14136
1.47
93.27
3.0
3.0
ng/l
218.6
245.0
2.53
3557
12917
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
6915
27376
1.35
92.54
3.2
2.9
e6/l
2.3
2.7
2.75
3858
14762
(36660697) Celiac disease serology panel - Serum
3312
11475
1.52
92.54
1.2
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
3107
10721
1.52
88.30
3.1
2.7
e9/l
4.0
4.3
5.69
2425
8005
(40761535) Cells panel - Urine sediment
3705
13368
1.46
84.53
3.5
3.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
3855
14112
1.44
81.34
2.4
2.6
e9/l
68.5
69.6
0.78
2936
10482
(3012095) Magnesium [Moles/volume] in Serum or Plasma
6902
27875
1.32
79.19
3.3
3.5
mmol/l
0.8
0.8
0.39
6419
25880
(3013139) Helicobacter pylori Ag [Presence] in Stool
2849
9885
1.51
78.59
1.2
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
10748
46040
1.26
77.47
3.4
3.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
10529
45112
1.25
75.34
4.0
4.1
%
88.3
89.1
2.47
10266
43983
(3037522) Nuclear Ab [Titer] in Serum
5517
21726
1.34
74.90
1.3
1.3
titre
508.2
531.3
0.38
1122
4378
(4010399)
3095
11040
1.47
74.45
1.4
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
3959
14803
1.41
73.91
2.4
2.3
ug/l
6.8
7.6
1.60
3417
12661
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
2799
9827
1.49
72.79
1.7
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
2444
8366
1.52
71.60
2.5
2.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
3362
12364
1.42
68.64
4.0
3.8
%
0.7
0.7
0.02
762
2829
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
3512
13040
1.41
67.95
2.7
2.6
ml/min/173m2
65.1
65.1
0.04
1402
5327
(3036481) Cortisol [Moles/volume] in Serum or Plasma
3841
14510
1.39
67.21
2.2
2.3
nmol/l
367.4
380.6
3.47
3491
13385
(3003458) Phosphate [Moles/volume] in Serum or Plasma
5658
22707
1.32
66.77
6.0
6.0
mmol/l
1.0
1.0
2.21
5248
21014
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
4442
17200
1.36
66.74
3.7
3.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
3076
11240
1.43
64.90
2.3
2.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
6570
27006
1.29
64.68
2.1
2.2
s
30.0
30.0
0.00
6386
26233
(40761536) Microorganisms panel - Urine sediment
3629
13663
1.39
64.65
4.2
3.8
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
3332
12417
1.40
62.93
3.8
4.0
ng/l
92.1
94.1
0.52
2839
10641
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
3662
13900
1.38
62.02
2.0
1.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
3646
13840
1.38
61.72
4.1
4.0
%
1.0
1.0
0.08
1033
4031
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
4055
15676
1.36
61.25
2.1
1.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
4855
19344
1.32
59.78
2.7
2.9
umol/l
8.2
9.5
3.11
4188
16863
(3020630) Protein [Mass/volume] in Serum or Plasma
3673
14034
1.37
59.64
2.5
2.5
g/l
66.3
66.2
0.22
3300
12710
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
4048
15737
1.35
58.84
2.6
2.4
u/l
37.9
51.4
1.51
3462
13506
(3017143) Hepatitis C virus Ab [Presence] in Serum
4687
18623
1.32
58.78
1.6
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
4454
17582
1.33
58.42
1.7
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
3263
12278
1.39
58.06
4.2
4.0
%
0.1
0.2
1.19
821
3102
(3021440) Promyelocytes/100 leukocytes in Blood
3461
13166
1.37
57.65
4.2
4.0
%
0.2
0.1
0.38
960
3743
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
3535
13501
1.37
57.45
4.2
3.8
mmol/l
1.2
1.2
0.34
3082
11829
(3022145) Colonoscopy Study observation
4632
18446
1.32
57.06
1.3
1.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
1925
6569
1.52
56.96
4.2
4.9
mmol/l
24.7
24.8
0.08
1759
6020
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
5039
20330
1.30
56.45
1.8
1.7
%
1.5
1.4
4.79
4367
18087
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
1997
6897
1.51
55.86
2.0
1.9
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
4985
20123
1.30
55.56
3.9
4.3
u/l
240.6
249.5
3.84
4687
18995
(46235355) HIV 1 and 2 tests - Meaningful Use set
6861
28923
1.25
53.82
1.8
1.8
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
1662
5562
1.55
53.64
1.1
1.1
u/ml
1.8
9.9
1.02
25
89
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
5779
23892
1.27
53.34
1.6
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
5144
21014
1.29
52.11
7.7
7.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
656
1701
1.99
51.03
2.1
1.9
mg/l
25.9
27.0
0.16
192
358
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
3235
12406
1.36
50.99
1.7
1.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
1819
6307
1.50
49.86
1.9
1.8
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
2910
11016
1.38
49.67
3.9
4.2
kpa
5.1
5.1
0.90
2672
10137
(3002256) Pathology report gross observation
5390
22276
1.27
49.58
1.3
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
2875
10874
1.38
49.32
3.9
4.2
ph
7.4
7.4
0.03
340
1429
(3049717) Cytology report of Urine Cyto stain
1848
6473
1.48
48.20
2.7
2.8
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
1150
3619
1.64
47.80
1.6
1.6
e6/l
15348.4
14401.9
0.19
839
2593
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
2092
7529
1.44
47.51
1.1
1.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
2775
10532
1.37
46.53
3.9
4.2
mmol/l
1.6
1.8
2.35
2032
7740
(3022313) Gas panel - Capillary blood
2133
7754
1.43
45.88
4.0
4.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
8755
38511
1.20
44.52
4.7
4.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
1334
4441
1.55
44.02
1.4
1.4
ug/g
274.6
267.2
0.61
789
2626
(3003694) ABO and Rh group [Type] in Blood
10830
48632
1.18
43.61
1.4
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
2516
9497
1.38
43.55
1.3
1.3
u/ml
222.9
263.5
1.22
2307
8808
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
1251
4119
1.57
43.30
1.4
1.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
3965
16074
1.29
42.06
2.2
2.3
g/l
0.2
0.2
0.10
3667
14838
(4024509)
482
1216
2.04
40.47
1.5
1.6
—
—
—
0
0
(3000492) Spirometry study
3912
15940
1.28
39.77
1.5
1.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
3119
12387
1.31
38.44
2.7
2.7
g/l
10.5
10.6
0.39
2829
11329
(3027801) Oxygen [Partial pressure] in Arterial blood
4854
20416
1.24
37.64
7.0
7.3
kpa
12.3
12.3
0.38
4637
19386
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
2644
10289
1.34
37.54
1.5
1.5
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
4855
20430
1.24
37.47
7.0
7.3
kpa
5.1
5.1
1.50
4640
19397
(3009466) Valproate [Moles/volume] in Serum or Plasma
711
2100
1.75
37.28
5.2
4.5
umol/l
356.3
358.2
0.12
612
1780
(3016502) Oxygen saturation in Arterial blood
4348
18093
1.26
37.02
7.5
7.7
%
95.8
95.4
3.76
4190
17407
(3003396) Base excess in Arterial blood by calculation
4839
20420
1.24
36.33
7.1
7.3
mmol/l
1.1
1.0
0.35
3778
15963
(3021788) Differential panel - Synovial fluid
868
2732
1.64
36.13
1.5
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
2436
9427
1.34
35.86
1.3
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
3354
13573
1.29
35.82
2.2
2.1
nmol/l
12.4
12.8
2.20
2952
12130
(3020779) Urea [Moles/volume] in Serum or Plasma
3885
16035
1.26
35.37
7.6
7.3
mmol/l
10.2
10.3
0.45
3689
15160
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1647
6026
1.41
34.11
2.3
2.3
g/l
3.1
3.1
0.19
1278
4699
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
298
663
2.31
33.95
12.8
13.4
nmol/l
807.7
1636.1
0.51
282
636
(3037121) Protein [Mass/volume] in Urine
1560
5657
1.43
33.94
3.2
3.2
g/l
0.4
0.3
0.62
645
2727
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
2104
8036
1.36
33.71
1.6
1.7
g/l
1.5
1.6
1.31
1771
6856
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
1397
4992
1.45
32.88
2.1
2.2
g/l
37.5
37.3
0.39
1180
4265
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
2503
9856
1.32
32.66
3.1
3.4
pmol/l
4.5
4.5
0.72
2233
8776
(3044941) Cell count panel - Synovial fluid
738
2300
1.65
31.96
1.4
1.4
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
3968
16617
1.24
31.69
8.0
8.1
g/l
121.3
121.5
0.16
3830
16026
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
305
708
2.21
31.61
18.5
18.3
nmol/l
1419.1
1377.9
0.38
293
663
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
1501
5490
1.41
31.14
2.3
2.4
g/l
0.9
0.9
0.02
1275
4691
(3004716) Salmonella sp identified in Stool by Organism specific culture
2001
7681
1.35
31.02
1.4
1.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
1606
5953
1.40
30.87
1.2
1.2
u/ml
1.1
0.8
0.51
156
560
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
906
3000
1.56
30.69
1.6
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
984
3327
1.53
30.37
1.3
1.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
2436
9653
1.31
30.34
1.9
1.9
g/l
1.3
1.3
0.02
2214
8780
(3026389) Candida sp identified in Specimen by Organism specific culture
639
1948
1.69
30.07
1.4
1.3
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
3788
15893
1.24
29.66
6.7
7.2
mmol/l
1.3
1.4
1.15
3642
15216
(3008898) HLA-B27 [Presence]
1363
4944
1.42
29.62
1.1
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
2847
11554
1.28
29.57
4.8
4.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
3001
12284
1.27
29.07
1.4
1.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
1410
5166
1.41
28.99
6.4
5.8
mmol/l
1.3
1.3
1.32
1259
4546
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1728
6558
1.36
28.80
2.2
2.2
g/l
7.4
7.4
0.25
1297
4789
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
1549
5782
1.39
28.58
2.8
2.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1723
6547
1.36
28.50
2.2
2.2
g/l
3.8
3.9
1.14
1255
4558
(3020961) Endomysium IgA Ab [Titer] in Serum
1884
7261
1.34
28.44
1.1
1.1
titre
173.5
215.7
0.36
52
193
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1724
6556
1.36
28.37
2.2
2.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1622
6131
1.37
27.73
2.2
2.2
g/l
10.3
10.2
0.19
1342
5162
(3028707) Methadone [Presence] in Urine by Screen method
678
2170
1.61
26.54
3.1
3.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
2332
9364
1.29
26.27
9.8
9.9
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
584
1810
1.66
25.93
1.6
1.5
%
58.4
60.1
0.43
375
1193
(3008152) Bicarbonate [Moles/volume] in Arterial blood
2680
10969
1.27
25.92
6.7
7.1
mmol/l
24.6
24.6
0.04
2510
10232
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
469
1368
1.76
25.83
1.5
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
1310
4841
1.40
25.66
1.6
1.6
iu/ml
8.6
6.7
0.12
286
1141
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
1231
4522
1.41
24.97
2.2
2.3
g/l
0.0
0.0
1.87
1123
4079
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
1263
4672
1.40
24.61
1.8
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
1166
4261
1.41
24.37
1.5
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
1862
7328
1.31
24.34
1.2
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
1314
4906
1.38
24.24
2.2
2.3
g/l
0.0
0.0
0.01
1203
4446
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
1210
4456
1.40
24.20
2.2
2.3
g/l
0.0
0.0
0.00
1118
4070
(3045424) Erythrocytes [Presence] in Urine
780
2650
1.52
23.65
1.4
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
1096
3983
1.42
23.64
1.5
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
1062
3845
1.42
23.38
1.6
1.6
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
1412
5368
1.36
23.31
3.2
3.2
mg/l
42.0
45.8
0.29
1134
4368
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
2553
10520
1.26
23.29
1.2
1.2
iu/ml
131.3
154.4
2.05
936
4003
(3018572) Chloride [Moles/volume] in Blood
1009
3625
1.44
23.17
7.4
6.8
mmol/l
105.0
105.0
0.23
912
3254
(3039000) Anion gap in Blood
1008
3625
1.43
23.03
7.4
6.8
mmol/l
11.1
11.4
1.07
911
3254
(3034860) Kappa light chains.free [Mass/volume] in Serum
1411
5374
1.36
23.03
3.2
3.2
mg/l
53.0
78.3
1.32
1129
4368
(3021387) Prolactin [Units/volume] in Serum or Plasma
1311
4939
1.37
22.91
1.7
1.7
mu/l
292.6
315.1
0.98
1197
4507
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
2943
18226
0.82
22.59
1.7
1.8
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
1365
5189
1.36
22.55
3.3
3.5
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
1374
5229
1.36
22.54
3.1
3.1
ratio
3.1
5.4
0.63
112
334
(3023511) Choriogonadotropin [Units/volume] in Urine
600
1949
1.58
22.20
1.3
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
601
1955
1.58
22.10
1.3
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
589
1919
1.58
21.54
1.3
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
587
1915
1.58
21.35
1.3
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
1250
4731
1.36
21.25
1.2
1.2
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
303
820
1.90
21.23
1.9
2.0
ug/l
2.1
2.3
0.33
255
691
(3014765) Yersinia sp identified in Stool by Organism specific culture
1246
4716
1.36
21.18
1.2
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
583
1905
1.57
21.07
1.3
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
1073
3968
1.39
21.00
3.3
3.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
581
1903
1.57
20.79
1.3
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
581
1903
1.57
20.79
1.3
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
2449
10178
1.25
20.72
1.3
1.3
au/ml
52.9
54.4
0.09
82
516
(44816559) Phosphatidylethanol [Mass/volume] in Blood
808
2847
1.46
20.59
1.4
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
1232
4684
1.36
20.37
1.2
1.2
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
307
849
1.86
20.19
1.9
1.9
ug/l
3.3
3.7
0.45
273
735
(3010421) pH of Blood
1201
4558
1.36
20.09
4.3
4.1
ph
7.4
7.4
0.53
1022
3897
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
1134
4265
1.37
20.07
1.1
1.1
u/ml
7.8
5.4
0.45
117
621
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
1299
4992
1.34
20.04
1.8
1.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
1770
7106
1.29
19.97
1.9
1.9
ug/l
2.1
2.4
0.57
1521
6243
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
705
2433
1.49
19.94
1.4
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
2089
8583
1.26
19.53
2.0
1.9
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
2663
11247
1.23
19.39
2.4
2.3
au/ml
22.2
25.0
0.42
109
799
(3014576) Chloride [Moles/volume] in Serum or Plasma
5107
22878
1.16
19.15
6.9
7.3
mmol/l
104.4
104.5
0.22
5000
22400
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
1159
4415
1.35
18.95
1.3
1.3
miu/ml
223.5
218.7
0.16
523
1949
(3042631) Mycobacterium sp identified in Specimen
653
2245
1.50
18.84
2.9
2.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
1312
5097
1.33
18.83
1.3
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
976
3622
1.39
18.76
3.3
3.5
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
261
708
1.89
18.25
12.5
10.7
mmol/l
0.6
0.6
0.28
237
649
(3019832) Treponema pallidum Ab [Presence] in Serum
3260
14156
1.19
17.78
1.7
1.6
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
921
3417
1.39
17.76
3.2
3.1
nmol/l
0.8
0.8
0.61
701
2640
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
2586
10991
1.22
17.69
7.2
8.0
mmol/l
24.8
24.7
0.75
2568
10879
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
1531
6139
1.29
17.47
2.3
2.3
ug/l
513.2
623.6
0.58
1446
5759
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
792
2872
1.42
17.41
1.4
1.4
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
1110
4257
1.34
17.41
1.3
1.2
u/ml
41.8
37.5
0.19
75
254
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
1657
6724
1.27
17.20
1.9
1.9
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
259
718
1.85
17.00
2.4
2.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
1722
7034
1.26
16.93
1.9
1.9
u/l
39.2
39.0
0.17
1533
6180
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
1459
5840
1.29
16.88
1.6
1.6
titre
291.8
314.1
0.11
71
218
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
1946
12196
0.81
16.67
1.4
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
1129
4379
1.33
16.44
2.5
2.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
891
3333
1.38
16.39
3.9
3.4
%
57.6
58.0
0.30
891
3333
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
880
3292
1.38
16.19
1.2
1.2
titre
256.2
101.6
0.65
21
61
(3044927) Protein electrophoresis panel - Urine
473
1569
1.55
16.16
1.2
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
1044
4016
1.34
16.08
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
1044
4018
1.34
16.03
1.3
1.3
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
1040
4003
1.34
15.96
4.3
4.1
kpa
5.0
5.0
0.13
1023
3893
(3027315) Oxygen [Partial pressure] in Blood
1045
4027
1.34
15.91
4.3
4.2
kpa
8.6
8.5
0.82
1027
3917
(3012501) Base excess in Blood by calculation
1039
4002
1.34
15.87
4.3
4.1
mmol/l
2.5
2.6
0.93
718
2718
(3000991) Gas panel - Venous blood
3512
15495
1.17
15.87
8.2
8.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
1321
5264
1.29
15.84
1.8
1.7
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
302
898
1.73
15.82
3.2
3.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
577
2009
1.48
15.75
1.3
1.2
mmol/l
7.4
7.4
0.01
422
1520
(3000330) Specific gravity of Urine by Test strip
2056
8654
1.23
15.47
3.5
3.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
461
1537
1.54
15.43
1.7
1.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
1007
3878
1.34
15.42
2.2
2.2
g/l
128.9
129.6
0.35
716
2845
(3010144) Erythrocytes [#/volume] in Synovial fluid
438
1447
1.56
15.27
1.4
1.4
e6/l
171695.1
110445.4
0.77
302
1016
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
613
2174
1.45
15.25
1.4
1.4
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
1804
7501
1.24
15.22
1.6
1.5
u/ml
20.6
13.2
0.79
54
209
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
1254
4993
1.29
15.15
1.6
1.6
g/l
1.2
1.2
1.37
1185
4726
(3008295) Osmolality of Serum or Plasma
462
1548
1.53
15.13
1.4
1.4
mosm/kgh2o
279.8
279.4
0.11
363
1180
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
1025
3970
1.33
15.10
1.3
1.3
u/ml
6.0
8.9
0.94
163
623
(3003181) Sodium [Moles/volume] in Urine
770
2861
1.39
14.80
1.4
1.4
mmol/l
62.9
63.3
0.08
627
2258
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
628
2260
1.43
14.49
1.4
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
709
2611
1.40
14.38
1.6
1.6
g/l
0.8
0.8
0.38
521
1977
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
1473
6030
1.26
14.27
1.6
1.7
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
1007
3924
1.32
14.26
1.3
1.3
u/ml
5.9
7.1
0.14
104
402
(3014007) Fractional oxyhemoglobin in Arterial blood
2606
11320
1.19
14.14
8.8
9.4
%
94.0
93.8
1.11
2596
11279
(3009214) Lutropin [Units/volume] in Serum or Plasma
1122
4446
1.30
14.08
1.4
1.4
u/l
9.5
9.7
0.22
920
3597
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
939
3631
1.33
14.03
2.0
1.8
pmol/l
198.1
202.9
0.62
875
3470
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
1210
4847
1.29
13.99
1.6
1.6
g/l
0.2
0.2
0.17
1147
4574
(3016879) Cocaine [Presence] in Urine
1334
5410
1.27
13.98
2.4
2.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
1719
7185
1.23
13.85
5.6
4.9
%
0.9
0.9
2.18
1615
6755
(3008757) Leukocyte morphology finding [Identifier] in Blood
520
1822
1.47
13.82
3.6
3.7
—
—
—
0
0
(4211845)
246
718
1.76
13.81
3.8
3.0
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
474
1632
1.49
13.74
3.2
3.3
%
58.6
59.4
0.25
304
1019
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
1023
4017
1.31
13.74
1.5
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
783
2966
1.36
13.42
1.7
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
1422
5848
1.25
13.27
2.3
2.1
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
134
321
2.14
13.23
1.4
1.3
%
35.1
35.5
0.04
90
212
(3028300) Cannabinoids [Presence] in Urine
1434
5914
1.25
13.06
2.3
2.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
923
3601
1.32
13.00
1.6
1.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
1605
6707
1.23
12.98
1.3
1.3
iu/l
28.7
28.8
0.05
1366
5768
(3034770) Mitochondria Ab [Titer] in Serum
1117
4475
1.29
12.93
1.2
1.2
titre
1077.2
924.3
0.27
36
118
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
2069
8873
1.20
12.93
4.0
4.8
mmol/l
24.1
24.1
0.23
1891
7922
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
2584
11311
1.18
12.83
8.8
9.3
%
0.7
0.7
0.23
2567
11242
(3027008) Opiates [Presence] in Urine
1427
5895
1.25
12.81
2.2
2.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
324
1043
1.60
12.70
2.7
2.2
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2586
11330
1.18
12.70
8.7
9.2
%
1.4
1.4
0.58
2574
11243
(3051387) C reactive protein [Mass/volume] in Capillary blood
929
3641
1.31
12.68
3.7
3.2
mg/l
26.0
28.7
1.29
532
2522
(3023419) Bacteria identified in Sputum by Culture
549
1981
1.42
12.56
2.5
2.4
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
1732
7323
1.22
12.53
5.5
4.8
%
1.6
1.6
0.03
1624
6891
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
473
1661
1.46
12.49
1.1
1.1
iu/ml
2.1
1.9
—
7
53
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
421
1444
1.50
12.48
1.6
1.5
%
28.9
28.8
0.03
259
951
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
1111
4470
1.28
12.46
1.9
2.0
mg/l
10.9
11.3
0.64
1034
4163
(3037556) Urate [Mass/volume] in Serum or Plasma
147
375
2.01
12.40
1.5
1.4
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
134
330
2.08
12.39
4.7
6.2
%
70.6
72.0
0.20
98
256
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
836
3241
1.33
12.34
1.2
1.2
u/ml
4.6
4.7
0.02
53
255
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
721
2742
1.35
12.10
1.1
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
1399
5812
1.24
11.97
2.3
1.9
—
—
—
0
0
(3024263) Appearance of Synovial fluid
253
779
1.67
11.84
1.8
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
684
2592
1.36
11.76
1.5
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
707
2694
1.35
11.73
1.2
1.3
u/l
46.5
35.6
0.77
612
2323
(3007566) Smooth muscle Ab [Titer] in Serum
1125
4569
1.27
11.72
1.2
1.2
titre
130.5
123.8
0.07
87
385
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
2204
9594
1.19
11.70
9.0
9.4
mmol/l
24.3
24.3
0.08
2062
8866
(3004616) Nuclear Ab [Presence] in Serum
523
1899
1.42
11.61
1.3
1.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
733
2814
1.34
11.59
3.2
3.3
%
1.6
1.5
0.33
561
2164
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
718
2749
1.34
11.56
1.1
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
992
3974
1.28
11.54
3.7
3.7
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
223
669
1.71
11.49
4.0
3.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
828
3241
1.31
11.46
1.2
1.2
u/ml
10.3
11.0
0.03
11
38
(3042111) Morphology [Interpretation] in Bone marrow Narrative
711
2722
1.34
11.46
1.5
1.6
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
601
2244
1.38
11.35
1.9
1.8
%
89.6
89.4
0.16
592
2212
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
780
3039
1.32
11.17
3.6
3.0
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
1277
5297
1.24
11.11
1.8
1.7
nmol/l
40.3
41.2
0.69
1232
5184
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
341
1149
1.52
11.05
1.7
1.6
u/ml
24.4
24.9
0.07
82
242
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
800
3133
1.31
11.05
1.2
1.2
u/ml
46.0
40.9
0.36
89
302
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
668
2549
1.35
11.02
1.2
1.2
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
342
1154
1.52
11.02
1.7
1.9
mmol/l
6.7
6.8
0.26
241
823
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
1178
4850
1.25
10.96
2.2
2.3
u/l
6518.8
5281.2
0.55
464
2027
(3048929) Epstein Barr virus Ab [Presence] in Serum
1163
4788
1.25
10.83
1.3
1.3
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
1478
6249
1.22
10.74
3.6
4.3
mmol/l
1.4
1.4
1.24
1454
6145
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
195
577
1.73
10.59
1.1
1.1
u/ml
4.2
9.9
1.71
32
103
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
597
2256
1.36
10.51
1.3
1.3
nmol/l
0.2
0.3
0.14
35
172
(3020891) Body temperature
1654
7086
1.20
10.51
4.6
5.0
—
—
—
0
0
(3012544) pH of Venous blood
3957
18135
1.13
10.38
3.9
4.2
ph
7.4
7.4
0.32
26
82
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
375
1308
1.47
10.35
1.5
1.5
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
453
1639
1.42
10.32
1.4
1.4
g/l
3.0
2.9
0.09
306
1145
(3000093) Morphology [Interpretation] in Blood Narrative
448
1620
1.42
10.24
1.1
1.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
596
2262
1.35
10.22
1.3
1.3
nmol/l
0.6
1.5
0.89
571
2181
(3024139) IgG subclass 3 [Mass/volume] in Serum
452
1638
1.42
10.21
1.4
1.4
g/l
0.4
0.4
0.41
303
1147
(3027135) IgG subclass 1 [Mass/volume] in Serum
452
1642
1.41
10.08
1.4
1.4
g/l
6.9
6.7
0.45
303
1147
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
435
1570
1.42
10.06
1.2
1.2
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
170
491
1.78
10.04
2.5
2.3
nmol/l
149.5
145.5
0.19
148
418
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
353
1225
1.48
10.01
2.2
2.2
nmol/l
17.8
17.1
0.76
330
1170
(3024928) Oxygen saturation in Venous blood
908
3668
1.27
9.96
3.3
3.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
1494
6373
1.21
9.95
3.0
3.3
u/ml
0.4
0.3
0.28
853
3588
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
319
1088
1.51
9.84
1.4
1.4
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
220
689
1.64
9.76
2.2
2.3
mmol/l
9.3
9.3
0.09
177
501
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
946
3852
1.26
9.73
1.8
1.8
iu/l
4.4
14.6
1.24
327
1415
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
313
1066
1.51
9.73
1.4
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
698
2734
1.31
9.70
1.1
1.1
—
—
—
0
0
(4035726)
3446
15731
1.13
9.63
1.4
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
477
1764
1.39
9.63
1.6
1.6
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
256
836
1.57
9.60
1.8
1.7
u/field
1.9
2.7
1.17
181
611
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
244
790
1.59
9.49
1.3
1.3
mmol/l
5.9
5.7
0.92
229
762
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
809
3242
1.28
9.48
1.3
1.3
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
599
2306
1.33
9.40
6.5
6.3
mg/l
12.0
11.5
2.02
542
2110
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
288
972
1.52
9.36
1.4
1.3
titre
54.1
73.5
0.45
27
79
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
440
1614
1.40
9.33
1.6
1.7
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
346
1214
1.46
9.33
1.2
1.2
u/ml
53.8
53.3
0.01
12
57
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
109
279
2.00
9.25
2.1
2.6
mmol/l
7.8
7.7
0.04
72
170
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
271
905
1.54
9.24
1.5
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
271
905
1.54
9.24
1.5
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
524
1982
1.36
9.24
1.3
1.3
nmol/l
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
272
911
1.53
9.16
1.5
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
692
2731
1.30
9.13
1.5
1.5
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
265
884
1.54
9.09
1.5
1.5
u/l
5.9
6.6
0.47
233
723
(4062490)
447
1654
1.39
9.03
1.4
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
613
2383
1.32
9.02
1.5
1.5
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
526
2002
1.35
8.93
2.9
2.6
%
13.1
13.2
0.58
521
1964
(21494755) Public health laboratory ask at order entry panel
3378
19292
0.89
8.93
1.3
1.3
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
293
1008
1.49
8.74
1.4
1.3
titre
383.3
448.9
0.12
27
94
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
524
2001
1.35
8.72
1.4
1.3
u/l
27.8
28.2
0.09
422
1679
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
336
1190
1.45
8.67
1.2
1.2
u/ml
46.2
42.1
0.11
24
103
(40767503) Oxygen content in Capillary blood by calculation
936
3861
1.25
8.67
2.5
2.5
%
16.1
16.4
0.84
457
2031
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
236
776
1.56
8.65
4.3
3.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
854
3489
1.26
8.60
5.5
5.5
iu/ml
1845.5
1172.5
0.24
132
495
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
1026
4279
1.23
8.60
1.1
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
536
2060
1.34
8.56
1.3
1.3
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
334
1187
1.44
8.48
1.2
1.2
u/ml
91.1
69.2
0.54
15
54
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
1139
4817
1.22
8.36
3.4
4.2
mg/l
1.6
1.5
1.14
1051
4419
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
387
1418
1.40
8.32
1.6
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
387
1418
1.40
8.32
1.6
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
387
1418
1.40
8.32
1.6
1.6
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
55
109
2.59
8.32
1.1
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
90
225
2.05
8.18
8.1
6.9
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
60
126
2.44
8.12
1.2
1.2
mmol/l
5.3
6.7
0.90
24
71
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
261
891
1.50
8.12
1.1
1.1
nmol/l
7.7
6.3
0.21
52
189
(3020876) Protein [Mass/time] in 24 hour Urine
389
1434
1.39
8.09
1.9
1.9
g/24h
0.9
1.1
0.27
18
85
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
753
3055
1.27
8.07
1.3
1.3
u/ml
269.1
264.1
0.19
478
1975
(3028271) Lactate [Moles/volume] in Capillary blood
711
2865
1.28
8.06
1.9
1.9
mmol/l
1.7
1.8
1.02
695
2795
(3032057) Clostridioides difficile [Presence] in Stool
119
331
1.84
8.03
1.8
1.9
—
—
—
0
0
(44806118)
493
1894
1.34
7.93
1.4
1.5
—
—
—
0
0
(44790047)
493
1894
1.34
7.93
1.4
1.5
—
—
—
0
0
(44790048)
493
1894
1.34
7.93
1.4
1.5
—
—
—
0
0
(44790049)
493
1894
1.34
7.93
1.4
1.5
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
318
1135
1.44
7.93
1.2
1.2
u/ml
3.4
7.5
0.88
17
83
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
457
1736
1.35
7.92
1.2
1.2
u/l
61.6
66.9
0.55
318
1177
(3034891) Synovial lining cells/100 cells in Synovial fluid
217
716
1.56
7.89
1.5
1.4
%
4.1
3.7
0.11
51
182
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
383
1415
1.39
7.88
1.3
1.3
nmol/l
1.5
1.4
0.41
343
1278
(40768800) Prostate Pathology biopsy report
889
3688
1.24
7.87
1.2
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
2152
9660
1.15
7.79
3.1
2.7
e6/l
0.2
0.3
3.00
2097
9394
(3002619) Bacteria identified in Specimen by Culture
105
285
1.89
7.65
1.3
1.3
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
224
751
1.53
7.61
1.5
1.6
umol/l
19.3
28.0
4.53
212
716
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
165
514
1.65
7.59
1.9
2.1
ug/l
58.3
61.7
0.16
159
505
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
434
1648
1.35
7.57
3.2
2.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
5222
24705
1.09
7.45
1.5
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
4027
18818
1.11
7.44
3.8
4.1
ug/l
20.5
29.5
1.10
3234
15288
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
373
1387
1.38
7.42
1.1
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
629
4070
0.79
7.41
1.5
1.7
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
298
1066
1.43
7.38
1.5
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
505
1972
1.32
7.31
1.6
1.6
—
—
—
0
0
(4094501)
1085
4635
1.20
7.24
1.1
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
234
802
1.50
7.21
1.4
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
234
802
1.50
7.21
1.4
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
252
877
1.47
7.20
1.5
1.6
—
—
—
0
0
(1002224) Polysomnography panel
1612
7130
1.16
7.17
1.1
1.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
224
762
1.51
7.15
2.3
2.1
ug/min
110.8
119.4
0.06
55
171
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
473
1837
1.32
7.13
1.1
1.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
982
4163
1.21
7.11
1.3
1.4
mg/l
507.8
561.8
1.66
926
3976
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
1072
4584
1.20
7.09
1.4
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
1234
5355
1.19
6.94
1.3
1.4
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
241
838
1.48
6.94
1.4
1.5
nmol/l
1.3
1.2
0.16
186
642
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
338
1252
1.39
6.92
1.8
1.8
mg/l
4.2
4.1
0.13
319
1194
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
368
1383
1.37
6.90
1.3
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
3768
17617
1.10
6.89
3.9
4.2
mmol/l
1.8
1.9
0.29
3045
14319
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
810
3382
1.23
6.82
1.4
1.5
u/ml
16.3
18.3
—
9
68
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
929
3939
1.21
6.74
1.6
1.5
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
699
4416
0.81
6.68
3.5
3.4
mmol/l
7.5
7.7
1.03
681
4350
(3021447) Carbon dioxide [Partial pressure] in Venous blood
3773
17675
1.10
6.64
3.9
4.2
kpa
5.8
5.8
0.13
3649
17130
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
742
3079
1.24
6.63
1.1
1.1
u/ml
1.2
1.6
0.64
302
1236
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
536
2140
1.29
6.63
1.1
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
233
814
1.47
6.58
9.2
11.5
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
192
644
1.53
6.58
2.2
2.0
%
8.7
8.5
0.07
186
626
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
244
862
1.45
6.52
1.6
1.5
mmol/l
8.1
7.8
0.75
151
525
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
228
795
1.47
6.51
6.2
6.2
u/ml
102.7
5585.0
0.82
49
169
(3044242) Glucose [Moles/volume] in Arterial blood
228
797
1.47
6.43
1.7
1.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
813
3420
1.22
6.41
1.4
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
240
850
1.45
6.34
1.8
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
240
850
1.45
6.34
1.8
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
240
850
1.45
6.34
1.8
1.8
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
185
621
1.53
6.34
1.3
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
879
5398
0.83
6.32
4.5
4.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
239
848
1.45
6.26
1.8
1.8
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
186
628
1.52
6.22
2.2
2.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
427
1670
1.31
6.19
3.7
3.7
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
83
225
1.89
6.16
1.6
1.6
—
—
—
0
0
(4015189)
128
396
1.66
6.15
2.2
2.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
1235
5420
1.17
6.13
3.8
4.5
mmol/l
3.9
3.9
0.14
1155
5109
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
861
3663
1.21
6.08
1.3
1.4
mmol/l
3.8
3.8
0.05
806
3430
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
145
465
1.60
6.06
2.5
2.5
au/ml
162.1
163.6
0.01
21
57
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
196
675
1.49
5.99
1.6
1.5
iu/ml
1748129.2
1917585.0
0.08
12
47
(1175426) CD3 cells/100 lymphocytes in Blood
339
1290
1.35
5.95
2.1
2.1
%
72.6
71.8
0.39
323
1239
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
1129
4938
1.18
5.86
1.4
1.4
iu/ml
13.0
10.5
0.26
25
114
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
640
2652
1.24
5.86
2.9
3.0
u/ml
3179.5
1742.3
0.46
37
148
(44813793)
279
1032
1.39
5.84
1.1
1.1
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
195
675
1.48
5.83
2.3
2.4
umol/l
55.7
55.8
0.03
160
561
(3011412) CD3 cells [#/volume] in Blood
413
1623
1.31
5.82
2.3
2.4
e9/l
1.2
1.2
0.35
259
954
(3014148) Varicella zoster virus Ab [Titer] in Serum
484
1943
1.28
5.80
1.2
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
112
340
1.69
5.79
1.1
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
451
1795
1.29
5.78
1.8
2.0
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
268
987
1.39
5.76
2.6
2.5
e9/l
0.4
0.3
0.46
259
958
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
517
2095
1.27
5.75
1.1
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
134
1062
0.65
5.74
1.3
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
332
1267
1.34
5.74
2.1
2.1
%
14.1
14.0
0.05
141
616
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
316
1198
1.35
5.70
2.1
2.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
861
3695
1.20
5.58
1.4
1.6
e6/l
1418.0
1811.3
0.22
704
3002
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
195
682
1.47
5.56
2.3
1.6
umol/l
116.1
117.0
0.01
96
353
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
860
3693
1.20
5.54
1.4
1.5
e6/l
20.8
27.4
0.52
663
2867
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
278
1038
1.37
5.53
1.0
1.0
ng/l
43.1
40.2
0.46
184
711
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
152
505
1.54
5.52
2.2
2.0
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
277
1035
1.37
5.49
1.0
1.0
ng/l
738.6
732.7
0.07
183
692
(40762814) Titanium [Mass/volume] in Blood
79
220
1.84
5.46
2.1
2.3
ug/l
4.2
4.0
0.07
32
67
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
733
3108
1.21
5.41
1.6
1.6
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
112
347
1.65
5.41
1.3
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
189
661
1.47
5.40
1.9
2.0
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
203
720
1.45
5.40
24.8
28.7
ug/l
111.2
116.3
0.51
168
608
(3020191) Ethanol [Moles/volume] in Serum or Plasma
346
1342
1.32
5.39
1.6
1.4
promille
1.3
1.4
0.17
262
1032
(3008037) Lactate [Moles/volume] in Venous blood
751
4605
0.83
5.38
3.3
3.3
mmol/l
1.6
1.6
0.87
729
4529
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
189
662
1.46
5.37
1.9
1.9
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
296
1124
1.35
5.32
1.1
1.1
—
—
—
0
0
(4198724)
185
647
1.47
5.30
3.0
2.1
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
155
523
1.52
5.27
1.3
1.2
g/l
0.3
0.3
1.45
120
423
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
835
3594
1.19
5.27
1.2
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
608
2537
1.23
5.27
1.1
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
64
168
1.95
5.27
2.1
2.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
190
669
1.46
5.26
1.9
2.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
411
2675
0.79
5.24
2.3
2.5
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
281
1062
1.36
5.22
1.1
1.3
mmol/l
32.9
35.3
0.98
235
919
(3023183) Ammonium ion [Moles/volume] in Plasma
874
3783
1.19
5.19
2.6
2.7
umol/l
34.7
34.1
0.20
746
3179
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
128
415
1.58
5.19
1.2
1.2
nmol/l
117.0
132.6
0.50
91
307
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
153
517
1.52
5.18
3.1
3.1
mg/l
7.5
7.8
0.18
124
422
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
274
1033
1.36
5.17
1.0
1.0
ng/l
307.3
316.0
0.19
184
722
(3025018) Bordetella pertussis Ab [Titer] in Serum
239
881
1.39
5.17
1.3
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
218
793
1.41
5.09
1.9
2.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
139
462
1.54
5.08
1.2
1.2
g/l
39.5
40.3
0.26
69
270
(3013166) Neutrophils/100 leukocytes in Synovial fluid
142
476
1.53
5.00
1.4
1.3
%
54.7
57.9
0.45
124
406
(3000034) Microalbumin [Mass/volume] in Urine
395
1578
1.28
4.99
3.0
3.0
mg/l
35.5
65.5
2.29
295
1142
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
210
762
1.41
4.98
1.4
1.3
%
66.3
60.7
0.36
30
89
(4146454)
446
1810
1.26
4.97
2.8
2.7
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
204
737
1.42
4.96
1.2
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
253
949
1.37
4.95
1.4
1.6
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
121
393
1.58
4.89
1.7
1.8
mmol/l
0.6
0.6
0.01
113
367
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
83
244
1.74
4.87
2.2
2.0
umol/l
17.1
16.6
0.16
83
244
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
142
480
1.52
4.83
1.2
1.2
%
110.0
112.8
0.57
125
421
(3015235) Bicarbonate [Moles/volume] in Capillary blood
1060
4692
1.16
4.81
3.2
3.2
mmol/l
24.5
24.8
1.24
919
4130
(3035637) Corticotropin [Mass/volume] in Plasma
504
2087
1.24
4.74
1.6
1.6
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
266
1015
1.34
4.69
1.6
1.6
u/l
6.4
6.5
0.02
127
512
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
66
183
1.85
4.69
2.1
2.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
553
2317
1.23
4.67
1.1
1.1
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
424
2710
0.80
4.67
2.3
2.5
mmol/l
105.6
105.6
0.04
417
2691
(3041354) Potassium [Moles/volume] in Venous blood
424
2710
0.80
4.67
2.3
2.5
mmol/l
4.1
4.1
0.93
417
2692
(3039162) Centromere protein B Ab [Units/volume] in Serum
478
1972
1.24
4.66
1.3
1.2
u/ml
50.8
48.6
0.06
33
123
(3038071) Oxygen [Partial pressure] in Mixed venous blood
106
338
1.61
4.64
7.9
8.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
150
518
1.48
4.64
1.1
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
584
2464
1.22
4.61
1.1
1.1
%
116.6
117.5
0.26
528
2228
(3008116) Ketones [Moles/volume] in Urine by Test strip
97
303
1.64
4.61
1.5
1.2
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
162
569
1.46
4.61
1.9
1.8
u/ml
55002.4
17697.5
0.31
25
68
(4306422)
603
2557
1.21
4.53
1.2
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
221
824
1.38
4.53
1.3
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
442
1814
1.25
4.52
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
297
1159
1.31
4.52
1.1
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
154
538
1.47
4.51
1.2
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
103
329
1.60
4.50
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
299
1170
1.31
4.47
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
299
1170
1.31
4.47
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
296
1157
1.31
4.46
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
299
1171
1.31
4.44
1.1
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
208
771
1.38
4.42
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
794
3461
1.18
4.41
1.4
1.5
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
296
1159
1.31
4.41
1.1
1.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
222
834
1.37
4.36
2.5
2.1
ml
1921.5
1934.9
0.07
195
735
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
519
2178
1.22
4.35
1.5
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
451
1867
1.24
4.30
1.3
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
613
2620
1.20
4.27
1.7
1.8
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
314
1246
1.29
4.25
1.7
1.6
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
17
25
3.48
4.24
3.9
4.4
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
157
558
1.44
4.24
2.7
2.5
ug/l
1.1
1.3
0.42
147
530
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
141
491
1.47
4.22
1.3
1.3
ug/l
579.2
154.9
0.82
65
275
(3006576) Bicarbonate [Moles/volume] in Blood
161
576
1.43
4.20
7.4
6.3
mmol/l
25.0
24.8
0.31
152
507
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
171
620
1.41
4.16
3.3
1.8
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
219
828
1.36
4.16
1.1
1.1
u/l
90.3
87.0
0.15
170
669
(3040151) Glucose [Moles/volume] in Capillary blood
486
2037
1.22
4.14
19.7
8.3
mmol/l
7.3
7.5
0.44
401
1679
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
317
1265
1.29
4.13
1.3
1.2
mmol/l
2.0
2.2
1.67
301
1175
(3043410) Blood group antigens tested for on Red Blood Cells
130
448
1.49
4.11
1.6
1.9
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
154
550
1.44
4.07
1.1
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
252
978
1.32
4.04
1.1
1.1
iu/ml
10.8
9.0
0.43
46
279
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
218
829
1.35
4.00
1.1
1.1
u/l
28.4
27.1
0.09
161
649
(3004119) Hemoglobin [Mass/volume] in Venous blood
2392
11248
1.09
3.99
3.5
3.6
g/l
129.1
128.6
0.48
2321
11025
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
151
540
1.43
3.98
1.5
1.3
pmol/l
16.4
15.4
0.40
123
462
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
251
976
1.32
3.97
1.2
1.2
u/l
33.9
25.4
0.95
213
845
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
241
932
1.33
3.96
1.1
1.2
ratio
1.1
1.1
1.55
89
313
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
258
1009
1.31
3.93
1.2
1.2
u/l
108.6
97.9
0.53
224
885
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
532
2265
1.21
3.90
1.1
1.1
g/l
1.5
1.5
0.12
473
2043
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
55
154
1.83
3.86
2.9
2.6
u/field
0.6
0.5
0.14
55
154
(3035947) Staphylolysin Ab [Units/volume] in Serum
226
870
1.33
3.85
1.1
1.1
iu/ml
2.7
4.2
—
10
72
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
252
987
1.31
3.81
1.2
1.2
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
37
90
2.11
3.81
1.2
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
296
1185
1.28
3.80
1.1
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
116
398
1.49
3.78
1.6
1.6
ug/l
8.5
9.1
0.66
116
398
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
192
723
1.36
3.78
1.1
1.2
u/ml
26.2
10.6
0.39
18
65
(3024354) Oxygen [Partial pressure] in Venous blood
3069
14621
1.08
3.77
3.4
3.6
kpa
4.6
4.6
0.57
2957
14100
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
25
51
2.51
3.75
1.4
1.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
211
808
1.34
3.73
1.5
1.8
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
465
1964
1.21
3.73
2.0
1.8
titre
1342.9
4199.6
2.18
28
97
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
116
400
1.49
3.70
7.5
8.6
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
116
400
1.49
3.70
1.1
1.1
u/ml
4.2
10.2
1.97
15
58
(3019977) pH of Arterial blood
244
957
1.31
3.67
2.7
2.3
ph
7.4
7.4
1.19
88
356
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
974
4382
1.14
3.63
2.3
2.4
ug/min
129.2
101.0
0.88
583
2655
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
249
981
1.30
3.63
1.2
1.2
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
808
3592
1.15
3.58
3.4
3.3
u/ml
664.0
988.3
0.38
745
3257
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
181
682
1.36
3.57
2.5
2.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
653
2856
1.17
3.57
1.1
1.1
u/ml
5.2
4.7
0.24
337
1423
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
275
1102
1.28
3.54
3.0
3.4
nmol/l
127.1
148.8
0.43
270
1084
(21494434) Karyotype in Bone marrow
356
1472
1.24
3.52
1.2
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
269
1076
1.28
3.51
1.3
1.3
u/ml
1.7
1.5
0.11
129
481
(40761539) Cells [Type] in Urine sediment by Light microscopy
121
426
1.46
3.51
1.2
1.2
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
370
1537
1.23
3.51
2.3
2.2
%
44.8
40.5
0.69
36
186
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
34
83
2.10
3.50
1.1
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
1218
6962
0.89
3.45
1.7
1.6
mg/l
4.3
3.2
1.15
882
4819
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
938
4226
1.14
3.45
1.3
1.2
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
305
1243
1.26
3.43
1.0
1.1
mg/l
288.1
290.8
0.25
272
1111
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
384
1607
1.23
3.41
1.5
1.6
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
238
942
1.30
3.38
2.3
2.3
umol/l
35.2
54.8
0.97
27
115
(3009871) Measles virus Ab [Titer] in Serum
141
515
1.40
3.37
1.8
1.6
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
711
3147
1.16
3.37
1.5
1.5
u/ml
117.6
111.9
0.42
147
671
(3034274) Bile acid [Moles/volume] in Serum --fasting
410
1730
1.22
3.36
2.1
2.2
umol/l
8.7
7.9
0.19
298
1272
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
273
1101
1.27
3.36
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
272
1097
1.27
3.35
1.0
1.1
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
549
2382
1.18
3.34
2.2
2.2
titre
2.3
8.9
1.85
20
74
(3019420) Tryptase [Mass/volume] in Serum or Plasma
215
842
1.31
3.31
1.4
1.5
ug/l
8.5
7.4
0.46
186
772
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
492
2117
1.19
3.29
1.4
1.3
pmol/l
277.6
298.5
0.51
381
1605
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
174
663
1.35
3.24
1.1
1.1
miu/ml
1497.0
1545.7
0.22
174
663
(3023420) DNA double strand Ab [Units/volume] in Serum
408
1728
1.21
3.24
1.4
1.5
iu/ml
23.5
31.9
0.98
22
70
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
48
137
1.80
3.23
1.2
1.2
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
180
691
1.34
3.20
1.0
1.1
%
95.9
96.8
0.12
141
535
(40763480) Human metapneumovirus Ag [Presence] in Specimen
29
69
2.15
3.19
1.6
1.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
129
469
1.41
3.19
1.2
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
623
2743
1.17
3.19
1.1
1.1
u/ml
1.3
1.0
0.40
275
1115
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
33
83
2.04
3.18
11.9
11.4
e6/l
218.0
174.3
0.28
24
61
(3010726) Horse dander IgE Ab [Units/volume] in Serum
592
2597
1.17
3.17
1.1
1.1
u/ml
1.4
2.0
0.89
136
625
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
604
2654
1.17
3.17
1.2
1.3
u/ml
3.4
4.5
0.78
188
934
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
195
759
1.32
3.16
1.1
1.1
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
16
28
2.93
3.16
1.0
1.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
357
1497
1.22
3.14
3.5
3.8
u/ml
40.0
54.3
1.33
352
1477
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
46
131
1.80
3.13
1.1
1.0
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
338
1411
1.23
3.11
1.3
1.3
mmol/l
12.1
11.9
0.08
86
406
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
1847
8692
1.09
3.11
2.9
3.1
%
1.3
1.2
0.82
1834
8651
(3024891) Influenza virus A+B Ag [Presence] in Specimen
1099
5040
1.12
3.08
1.2
1.2
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
92
316
1.49
3.06
1.3
1.3
mu/l
76.9
69.6
0.16
65
238
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
102
358
1.46
3.06
1.5
1.6
ug/l
0.4
0.4
0.44
61
234
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
117
422
1.42
3.04
1.2
1.2
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
48
140
1.76
3.04
1.8
1.7
mg/l
1.4
1.8
0.88
40
125
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
321
1337
1.23
3.03
1.5
1.4
u/l
12.6
13.2
0.92
308
1285
(3011985) Renin [Units/volume] in Plasma
525
2292
1.18
3.01
1.5
1.5
mu/l
57.9
68.8
0.59
460
2049
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
133
492
1.39
3.01
1.2
1.2
%
27.9
20.7
0.36
15
86
(40765096) Chromosome analysis panel by Banding
122
445
1.41
2.99
1.1
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
79
264
1.53
2.99
3.1
2.8
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
427
1833
1.20
2.98
2.4
2.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
1712
9540
0.92
2.96
1.7
1.7
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
44
126
1.79
2.96
1.1
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
408
1746
1.20
2.95
1.2
1.2
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
402
1718
1.20
2.95
1.4
1.3
u/l
316.7
469.7
2.14
379
1622
(3036489) Thrombin time
1464
6835
1.10
2.94
2.0
2.3
s
21.3
21.8
1.83
1271
6045
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
344
1449
1.22
2.93
2.0
2.1
u/field
1.8
2.4
1.03
163
529
(3012441) Differential panel - Pleural fluid
461
2000
1.18
2.87
1.6
1.5
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
199
789
1.29
2.86
1.6
1.6
mmol/24h
6.5
6.0
0.25
15
65
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
1805
8522
1.09
2.85
2.9
3.1
%
0.7
0.7
1.66
1729
8187
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
15
27
2.85
2.85
1.2
1.1
%
3.1
2.4
0.25
15
27
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
196
777
1.29
2.83
1.2
1.3
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
437
1890
1.19
2.83
1.1
1.1
%
96.2
96.1
0.04
409
1775
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
101
363
1.43
2.72
1.2
1.3
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
44
130
1.73
2.70
2.6
3.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
130
489
1.36
2.70
1.9
1.7
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
301
1264
1.22
2.68
1.2
1.2
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
42
123
1.75
2.66
11.4
6.7
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
354
1512
1.20
2.65
4.7
5.0
u/ml
73.3
122.1
1.06
111
458
(3047007) Chlamydophila sp Ab [Presence] in Serum
528
2334
1.16
2.64
1.2
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
174
687
1.30
2.62
1.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
457
2001
1.17
2.59
1.7
1.5
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
62
204
1.56
2.56
1.1
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
399
1731
1.18
2.53
1.2
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
509
2252
1.16
2.53
1.0
1.1
u/ml
3.2
4.8
1.32
198
862
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
177
704
1.29
2.53
1.6
1.6
nmol/l
5.5
7.5
0.22
148
585
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
238
983
1.24
2.50
2.6
2.7
%
40.9
37.6
1.21
82
314
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
318
1354
1.20
2.49
1.3
1.3
u/l
14.1
12.8
0.39
293
1246
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
95
344
1.42
2.49
1.5
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
152
594
1.31
2.48
1.3
1.2
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
43
130
1.69
2.47
1.5
1.2
pmol/l
13.3
16.6
0.27
37
114
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
113
423
1.37
2.45
1.1
1.1
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
106
393
1.38
2.44
1.3
1.3
umol/l
16.8
16.8
0.00
92
352
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
69
236
1.50
2.42
1.1
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
60
199
1.55
2.42
1.3
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
263
1103
1.22
2.41
1.2
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
423
1853
1.17
2.41
1.4
1.6
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
132
508
1.33
2.41
1.1
1.2
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
99
364
1.39
2.40
1.7
1.7
au/ml
74.4
139.7
—
9
41
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
281
1188
1.21
2.39
2.3
2.5
e6/l
522.0
516.8
0.04
237
974
(3003721) Smooth muscle Ab [Units/volume] in Serum
30
82
1.87
2.38
1.2
1.1
u/ml
1.3
2.4
—
5
8
(3051101) Glucose [Moles/volume] in Cord blood
50
395
0.65
2.36
7.2
5.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
583
2621
1.14
2.35
1.3
1.3
u/ml
4.3
4.0
0.17
249
1167
(3051611) Lipemic interference index of Serum or Plasma
438
1929
1.16
2.35
3.2
3.8
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
75
263
1.46
2.35
3.3
2.6
u/l
1968.9
1936.2
0.01
67
238
(3035611) Eosinophils/100 leukocytes in Synovial fluid
37
109
1.74
2.34
1.7
1.6
%
1.3
0.8
0.45
28
85
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
58
193
1.54
2.32
1.4
1.6
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
65
222
1.50
2.31
1.1
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
111
419
1.36
2.31
1.1
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
41
125
1.68
2.31
1.1
1.0
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
230
957
1.23
2.29
3.1
3.3
mu/l
27.8
25.3
0.43
217
902
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
121
464
1.34
2.28
2.0
2.1
u/l
24.8
44.2
1.65
112
423
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
214
1348
0.81
2.28
1.2
1.3
g/l
1.5
1.5
0.06
19
63
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
10
16
3.20
2.27
2.0
2.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
10
16
3.20
2.27
2.0
1.9
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
10
16
3.20
2.27
2.0
1.9
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
10
16
3.20
2.27
1.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
10
16
3.20
2.27
1.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
10
16
3.20
2.27
1.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
33
95
1.78
2.25
1.1
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
113
430
1.35
2.25
1.1
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
113
430
1.35
2.25
1.4
1.4
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
580
2618
1.14
2.22
1.5
1.5
g/l
31.1
32.8
2.43
512
2317
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
129
502
1.32
2.21
3.1
2.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
129
502
1.32
2.21
3.1
2.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
3400
16569
1.06
2.21
1.4
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
233
976
1.22
2.20
1.2
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
471
2099
1.15
2.18
1.0
1.1
u/ml
4.2
4.9
0.31
192
841
(3034092) Cytoplasmic Ig cells/100 cells in Blood
57
192
1.52
2.18
10.1
8.6
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
35
104
1.72
2.17
1.0
1.1
—
—
—
0
0
(3007147) Virus identified in Stool by Electron microscopy
6
6
5.12
2.15
1.0
1.0
—
—
—
0
0
(4268621)
403
1778
1.16
2.15
2.3
2.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
244
1031
1.21
2.13
6.2
6.6
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
180
736
1.25
2.13
35.7
35.7
ug/l
7.6
7.2
1.19
169
661
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
548
2473
1.14
2.13
1.1
1.1
u/ml
2.3
3.1
1.24
248
1267
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
14
29
2.47
2.12
6.7
3.6
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
34
101
1.72
2.11
1.1
1.0
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
122
475
1.32
2.10
2.2
1.9
mg/l
9.8
9.1
0.58
97
389
(3028717) Thiamine [Mass/volume] in Blood
47
153
1.57
2.09
1.2
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
166
674
1.26
2.09
2.3
3.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
96
363
1.36
2.02
1.1
1.1
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
85
315
1.38
2.02
1.1
1.1
umol/24h
0.7
0.7
0.14
36
155
(3020123) Porphyrins [Interpretation] in Serum or Plasma
27
76
1.82
2.00
1.1
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
370
1632
1.16
2.00
1.4
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
130
515
1.29
2.00
1.1
1.1
—
—
—
0
0
(3007542) Rye IgE Ab [Units/volume] in Serum
24
65
1.89
1.99
1.0
1.0
u/ml
1.2
0.1
0.46
11
29
(21491868) Cryoglobulin [Mass/volume] in Serum
147
592
1.27
1.99
1.2
1.2
g/l
0.2
0.4
—
8
39
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
267
1148
1.19
1.97
2.4
2.6
e9/l
0.2
0.2
1.27
232
972
(3012898) Urea [Moles/volume] in Urine
50
168
1.52
1.96
1.2
1.7
mmol/l
156.3
169.6
0.32
45
148
(3018001) Oat IgE Ab [Units/volume] in Serum
31
92
1.73
1.95
1.1
1.0
u/ml
0.3
0.3
0.11
12
33
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
111
432
1.32
1.95
1.1
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
147
594
1.27
1.95
1.4
1.4
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
82
306
1.37
1.89
2.9
2.9
ml/dl
14.8
14.6
0.31
75
284
(3028626) Oxygen [Partial pressure] in Capillary blood
967
4536
1.09
1.89
4.0
4.4
kpa
8.2
8.2
0.27
887
4227
(3024869) Neuronal Ab [Presence] in Serum
79
293
1.38
1.89
1.1
1.1
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
35
109
1.65
1.88
1.8
1.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
577
2639
1.12
1.85
1.1
1.1
au/ml
13.9
10.9
0.23
27
189
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
298
1302
1.17
1.85
1.2
1.2
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
31
94
1.69
1.83
1.1
1.0
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
420
1885
1.14
1.82
1.0
1.1
u/ml
0.2
0.5
1.06
107
407
(40768446) Kidney Pathology biopsy report
168
697
1.24
1.80
1.7
1.7
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
79
296
1.37
1.80
1.4
1.1
mg/l
25.9
56.9
0.38
60
214
(3006442) Creatine [Moles/volume] in Serum or Plasma
285
1244
1.17
1.80
1.5
1.5
umol/l
65.3
73.1
1.18
18
118
(3007700) Barley IgE Ab [Units/volume] in Serum
20
53
1.93
1.78
1.1
1.1
u/ml
1.0
0.6
0.15
11
27
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
30
91
1.69
1.78
1.1
1.0
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
94
363
1.33
1.77
1.2
1.2
pmol/l
263.5
310.5
0.60
64
263
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
548
2507
1.12
1.77
2.8
2.8
u/ml
724.2
727.3
0.00
532
2406
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
16
39
2.10
1.76
9.8
5.2
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
179
751
1.22
1.74
2.2
2.0
ug/l
22.1
248.1
1.60
165
717
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
40
132
1.55
1.73
1.5
2.3
—
—
—
0
0
(3001729) Color of Synovial fluid
40
132
1.55
1.73
1.7
1.5
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
46
157
1.50
1.72
2.0
2.6
mg/l
18.9
22.3
0.93
41
151
(3013247) Albumin in CSF/Albumin in Serum or Plasma
53
385
0.70
1.71
1.1
1.1
mg/g
6.2
7.7
1.26
47
370
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
78
295
1.35
1.69
1.2
1.1
pmol/l
4.9
8.9
—
9
40
(3005011) Chlamydia sp Ab [Titer] in Serum
60
217
1.42
1.69
1.6
1.6
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
40
133
1.54
1.68
1.0
1.1
iu/ml
9.5
19.7
0.81
14
49
(3033086) Enterovirus NOS Ab [Titer] in Serum
16
40
2.05
1.66
1.0
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
92
358
1.32
1.66
1.6
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
244
1060
1.18
1.66
1.2
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
204
874
1.20
1.63
1.2
1.2
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
84
324
1.33
1.62
3.3
5.4
u/l
109.3
50.2
0.58
24
134
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
289
1276
1.16
1.62
2.4
2.5
e6/l
668.6
668.6
0.00
117
488
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
57
404
0.72
1.61
1.1
1.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
22
63
1.79
1.59
1.0
1.1
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
23
67
1.76
1.58
1.2
1.1
ng/l
3118.3
4012.6
0.26
15
44
(3013293) Extractable nuclear Ab [Presence] in Serum
62
229
1.39
1.57
1.7
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
125
511
1.25
1.57
2.9
3.0
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
276
1634
0.86
1.56
2.1
2.3
ml
664.7
654.9
0.14
174
1123
(3029075) Extractable nuclear Ab panel - Serum
113
457
1.27
1.56
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
530
3011
0.90
1.55
1.1
1.1
—
—
—
0
0
(4212803)
44
153
1.47
1.54
1.1
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
384
1738
1.13
1.53
1.1
1.1
au/ml
51.3
72.0
—
6
18
(3003740) Influenza virus B Ag [Presence] in Specimen
531
3013
0.90
1.52
1.1
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
715
3349
1.10
1.52
1.8
1.7
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
99
396
1.28
1.50
1.1
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
87
342
1.30
1.50
1.3
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
71
271
1.34
1.49
1.6
1.3
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
155
654
1.21
1.48
1.1
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
50
180
1.42
1.48
1.1
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
1332
6402
1.07
1.48
1.9
1.8
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
7
13
2.76
1.47
1.0
1.1
—
—
—
0
0
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
35
117
1.53
1.47
1.1
1.3
mg/l
40.6
46.5
0.85
14
33
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
22
65
1.73
1.46
1.2
1.0
pmol/l
185.7
225.9
0.20
16
38
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
23
69
1.71
1.46
1.9
1.5
u/l
0.0
0.4
—
6
21
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
594
2765
1.10
1.45
1.1
1.1
iu/ml
96.9
4841.1
0.60
149
534
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
24
73
1.68
1.45
1.0
1.0
u/ml
0.1
0.1
0.00
13
25
(3007463) Buprenorphine [Presence] in Urine
18
50
1.84
1.44
8.4
3.7
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
508
2879
0.90
1.44
3.5
3.5
u/ml
31.8
39.0
0.88
488
2778
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
394
1795
1.13
1.43
1.1
1.1
au/ml
17.3
4.0
—
6
7
(3045788) Cell count panel - Pleural fluid
398
1815
1.12
1.43
1.6
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
207
901
1.18
1.42
1.3
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
207
901
1.18
1.42
1.3
1.6
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
156
662
1.21
1.42
1.9
2.2
%
29.0
28.7
0.11
147
628
(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid
20
58
1.77
1.42
5.1
5.4
mmol/l
17.2
16.9
0.06
15
53
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
1050
5762
0.93
1.41
1.5
1.3
—
—
—
0
0
(3037297) Penicillin G IgE Ab [Units/volume] in Serum
22
66
1.71
1.40
1.0
1.0
u/ml
0.0
0.1
0.04
11
20
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
29
94
1.58
1.40
1.1
1.2
u/l
101.8
40.1
0.68
23
66
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
101
410
1.26
1.38
1.1
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
680
3792
0.92
1.38
1.4
1.4
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
139
585
1.22
1.38
2.7
3.0
umol/l
28.0
29.5
0.82
101
442
(3042733) HLA Ab [Presence] in Serum
135
567
1.22
1.37
5.2
4.7
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
683
3806
0.92
1.37
1.4
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
298
1735
0.88
1.36
1.1
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
132
554
1.22
1.35
1.7
2.0
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
45
162
1.42
1.35
1.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
48
175
1.41
1.35
1.0
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
683
3803
0.92
1.35
1.4
1.4
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
59
223
1.36
1.35
1.0
1.0
ug/l
79.6
82.0
0.19
49
185
(3017315) Amylase [Enzymatic activity/volume] in Urine
216
949
1.17
1.34
1.2
1.2
u/l
344.9
336.8
0.03
190
900
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
72
281
1.31
1.34
1.4
1.4
%
8.7
11.3
0.59
36
141
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
127
532
1.22
1.33
1.3
1.2
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
109
449
1.24
1.33
1.1
1.1
u/ml
3.9
10.8
0.45
52
259
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
147
625
1.21
1.33
1.1
1.1
—
—
—
0
0
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
5
8
3.20
1.32
1.0
1.0
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
8
85
0.48
1.32
4.0
2.3
mmol/l
4.7
4.3
—
8
77
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
434
2001
1.11
1.31
3.0
3.2
nmol/l
17.6
6.8
0.40
420
1945
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
683
3797
0.92
1.31
1.4
1.4
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
15
134
0.57
1.30
1.1
1.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
84
337
1.28
1.28
1.8
2.6
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
38
134
1.45
1.28
1.1
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
69
270
1.31
1.27
1.7
1.7
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
36
126
1.46
1.26
1.2
1.1
u/l
8.0
12.8
1.05
36
126
(3030313) Adrenal Ab [Titer] in Serum
20
164
0.62
1.25
1.1
1.1
—
—
—
0
0
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
17
49
1.78
1.25
1.0
1.0
u/ml
0.1
0.2
—
8
23
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
58
222
1.34
1.24
1.2
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
278
1254
1.14
1.23
1.7
1.8
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
19
57
1.71
1.23
1.1
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
463
2151
1.10
1.23
1.5
1.5
e6/l
55117.6
58493.5
0.08
271
1303
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
166
721
1.18
1.22
1.4
1.3
umol/l
4.2
4.7
0.83
158
655
(3024932) HLA-DR beta [Type]
132
562
1.20
1.21
1.1
1.1
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
68
268
1.30
1.20
1.1
1.4
ng/l
1281.8
145.8
0.44
43
187
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
162
703
1.18
1.20
1.1
1.1
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
5
9
2.85
1.19
1.0
1.2
nmol/24h
25.8
28.5
—
5
9
(3043614) Bacteria identified in Aspirate by Culture
5
9
2.85
1.19
1.0
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
184
808
1.17
1.19
1.8
2.2
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
7
14
2.56
1.17
1.6
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
135
578
1.20
1.17
1.0
1.0
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
388
1792
1.11
1.17
1.4
1.3
mmol/l
6.2
6.4
0.57
353
1646
(42529582) MDA5 Ab [Presence] in Serum by Line blot
87
356
1.25
1.16
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
87
356
1.25
1.16
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
87
356
1.25
1.16
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
87
356
1.25
1.16
1.1
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
60
234
1.31
1.15
1.8
1.9
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
507
2375
1.09
1.15
1.6
1.5
e6/l
2477.0
2881.9
0.31
360
1716
(3022493) Free Hemoglobin [Mass/volume] in Plasma
178
782
1.17
1.15
4.0
5.3
mg/l
1385.4
2247.4
0.25
126
556
(3006245) CD3-CD19+ cells/100 cells in Blood
155
674
1.18
1.14
2.0
2.3
%
9.9
11.3
0.71
144
628
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
61
240
1.30
1.11
1.3
1.4
nmol/l
164592.1
270209.9
0.22
48
198
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
106
446
1.22
1.11
1.0
1.0
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
42
156
1.38
1.11
2.2
2.6
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
44
165
1.37
1.10
1.1
1.1
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
158
691
1.17
1.10
1.5
1.4
%
61.6
63.2
0.23
131
558
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
281
1281
1.12
1.09
1.1
1.1
mg/l
265.1
286.4
0.81
244
1139
(40768793) Breast Pathology biopsy report
684
3764
0.93
1.07
1.4
1.3
—
—
—
0
0
(3051671) S100 calcium binding protein B [Mass/volume] in Serum
5
57
0.45
1.07
1.6
2.0
ug/l
0.1
0.4
—
5
51
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
28
97
1.48
1.06
3.3
3.3
—
—
—
0
0
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
21
68
1.58
1.06
1.2
1.3
u/field
1.2
1.0
0.32
12
39
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
45
171
1.35
1.05
1.1
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
160
704
1.16
1.04
1.7
2.0
umol/l
29.7
28.9
0.47
151
676
(3020874) Milk IgE Ab [Units/volume] in Serum
237
1074
1.13
1.03
1.1
1.1
u/ml
4.3
3.0
0.22
78
300
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
207
930
1.14
1.02
1.5
1.7
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
158
697
1.16
1.01
1.7
2.0
umol/l
2.0
2.0
0.04
149
649
(3001893) Eosinophils/100 leukocytes in Pleural fluid
134
584
1.18
1.00
1.4
1.4
%
2.5
2.5
0.02
112
487
(3021367) Citalopram [Moles/volume] in Serum or Plasma
10
26
1.97
0.99
1.8
1.2
nmol/l
89.8
152.8
—
5
17
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
170
756
1.15
0.98
1.8
1.9
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
55
218
1.29
0.98
1.0
1.0
—
—
—
0
0
(3025315) Body weight
25
184
0.70
0.98
5.2
4.4
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
315
1457
1.11
0.97
1.2
1.2
titre
112.3
152.3
0.41
13
44
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
56
223
1.29
0.97
1.1
1.1
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
11
30
1.88
0.97
1.4
1.1
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
25
87
1.47
0.95
1.0
1.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
1183
5761
1.05
0.95
2.3
2.7
%
92.0
91.0
0.69
1103
5400
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
338
1572
1.10
0.95
1.0
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
315
1460
1.11
0.94
1.2
1.2
titre
178.0
187.3
0.07
49
244
(3018133) Calcium [Moles/volume] in Urine
65
265
1.26
0.94
1.8
2.1
mmol/l
2.5
2.5
0.01
57
238
(3004446) Plasmodium sp identified in Blood by Light microscopy
28
200
0.72
0.93
2.8
2.6
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
120
524
1.17
0.90
1.4
1.4
%
21.9
20.7
0.18
109
469
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
24
84
1.46
0.90
1.0
1.1
u/ml
20.7
22.9
—
6
11
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
24
84
1.46
0.90
1.0
1.1
u/ml
52.5
33.2
—
7
13
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
16
126
0.65
0.89
1.8
2.8
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
25
89
1.44
0.87
1.8
1.4
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
36
243
0.76
0.85
1.6
1.4
%
75.9
74.1
0.16
28
199
(3021901) Oxygen saturation in Capillary blood
729
3516
1.06
0.85
3.0
2.9
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
32
120
1.37
0.84
4.8
4.6
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
26
94
1.42
0.84
1.0
1.0
u/ml
0.3
1.0
0.79
15
67
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
47
305
0.79
0.83
2.6
2.3
mg/l
117.1
51.5
—
5
62
(3020618) Glucose [Moles/volume] in Synovial fluid
16
52
1.58
0.83
1.1
1.1
mmol/l
6.0
5.1
—
9
40
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
759
3670
1.06
0.82
1.5
1.4
pmol/l
158.7
152.3
0.10
741
3586
(43055514) Macroprolactin [Presence] in Serum or Plasma
84
359
1.20
0.82
1.4
1.5
—
—
—
0
0
(3019174) dRVVT (LA screen)
37
143
1.33
0.82
1.1
1.2
—
—
—
0
0
(40759632) Porphyrins [Mass/mass] in Stool
0
15
0.00
0.82
0.0
1.1
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
14
44
1.63
0.82
1.1
1.3
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
43
170
1.30
0.82
1.1
1.1
g/l
18.0
16.9
0.42
38
156
(43055442) Apixaban [Mass/volume] in Serum or Plasma
60
248
1.24
0.81
1.5
1.6
ug/l
109.6
111.7
0.06
50
204
(3019768) Coxiella burnetii Ab [Presence] in Serum
29
108
1.38
0.80
1.3
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
109
478
1.17
0.80
1.5
1.4
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
14
110
0.65
0.79
2.4
3.2
%
12.5
14.7
—
6
34
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
34
228
0.76
0.78
1.0
1.0
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
289
1351
1.10
0.78
1.1
1.2
mg/l
40.1
46.9
1.42
236
1143
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
293
1639
0.92
0.76
1.3
1.3
pmol/l
156.5
74.5
0.43
101
449
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
111
490
1.16
0.76
1.2
1.1
%
92.4
87.3
0.61
58
228
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
41
163
1.29
0.76
1.3
1.2
ug/l
117.4
108.1
0.14
28
102
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
490
2344
1.07
0.76
1.4
1.4
nmol/l
0.3
0.4
0.83
369
1837
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
13
41
1.62
0.76
1.1
1.0
—
—
—
0
0
(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum
13
41
1.62
0.76
1.0
1.0
u/ml
0.3
0.3
—
5
20
(3021706) Oxygen [Partial pressure] in Arterial cord blood
36
238
0.77
0.75
1.0
1.0
kpa
3.8
3.2
0.73
31
194
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
83
358
1.19
0.75
2.7
2.7
ng/l
99.7
105.3
0.10
42
172
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
7
19
1.89
0.75
1.3
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
229
1061
1.11
0.75
1.2
1.3
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
49
200
1.26
0.75
1.1
1.1
u/l
17.3
21.2
0.80
32
130
(3011335) Digoxin [Mass/volume] in Serum or Plasma
40
159
1.29
0.75
2.3
2.4
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
34
132
1.32
0.74
1.2
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
131
588
1.14
0.73
1.1
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
372
1765
1.08
0.73
1.6
1.8
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
1353
6664
1.04
0.73
3.4
3.5
u/ml
1870.4
2469.4
0.18
1142
5753
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
1111
5449
1.05
0.73
2.5
2.9
g/l
3.6
3.6
0.32
1060
5199
(44806420)
97
577
0.86
0.72
2.2
2.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
572
3110
0.94
0.71
1.4
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
1363
6719
1.04
0.71
1.5
1.5
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
15
113
0.68
0.71
1.0
1.0
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
17
125
0.70
0.71
1.0
1.0
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
44
179
1.26
0.70
1.2
1.1
u/ml
0.0
0.6
1.45
26
117
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
49
202
1.24
0.70
1.7
2.4
mmol/l
1.2
1.3
0.08
31
139
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
100
442
1.16
0.69
1.6
1.4
%
24.1
21.6
0.37
84
354
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
114
509
1.15
0.69
1.1
1.2
%
108.5
104.9
0.38
106
471
(3023383) Lactate [Moles/volume] in Pleural fluid
129
581
1.14
0.69
1.3
1.3
mmol/l
3.7
3.5
0.36
114
534
(3046904) Somatotropin [Units/volume] in Serum or Plasma
11
34
1.66
0.69
1.3
2.4
mu/l
2.0
1.7
0.19
11
34
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
1076
5283
1.04
0.68
2.5
2.7
%
190.5
192.8
0.34
1019
5016
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
37
240
0.79
0.68
1.0
1.0
kpa
6.9
7.2
0.43
31
197
(3006598) pH of Arterial cord blood
37
240
0.79
0.68
1.0
1.0
—
—
—
0
0
(4133840)
109
486
1.15
0.68
1.2
1.2
—
—
—
0
0
(3027874) Urate [Moles/volume] in Urine
16
55
1.49
0.68
1.0
1.1
mmol/l
2.0
12.6
—
9
35
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
213
1200
0.91
0.67
1.1
1.1
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
19
68
1.43
0.67
1.1
1.1
nmol/l
277.7
284.0
0.05
19
68
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
42
171
1.26
0.67
1.2
1.2
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
51
1.51
0.67
1.1
1.0
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
87
0.65
0.66
1.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
571
3095
0.94
0.66
1.4
1.4
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
5
14
1.83
0.66
1.0
1.6
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
33
131
1.29
0.64
1.2
1.2
nmol/l
12.7
15.4
—
9
36
(3025130) Human papilloma virus identified in Specimen
426
2045
1.07
0.63
1.7
1.7
—
—
—
0
0
(4027681)
218
1019
1.10
0.63
1.2
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
200
931
1.10
0.63
1.1
1.1
u/l
1.1
1.1
0.65
100
445
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
8
25
1.64
0.63
1.0
1.2
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
105
471
1.14
0.62
1.4
1.5
mu/l
369.3
666.6
2.13
100
448
(3041918) Cholesterol [Moles/volume] in Pleural fluid
75
328
1.17
0.62
1.2
1.2
mmol/l
1.8
1.5
0.78
40
205
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
111
501
1.14
0.60
1.1
1.1
%
92.3
88.5
0.59
57
232
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
22
83
1.36
0.60
1.4
2.1
nmol/l
2.3
14.8
1.23
22
77
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
32
128
1.28
0.60
1.1
1.1
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
6
17
1.81
0.60
8.0
6.3
—
—
—
0
0
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
24
92
1.34
0.60
1.0
1.1
u/ml
4.3
1.4
0.36
17
71
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
13
44
1.51
0.60
1.2
1.2
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
107
483
1.14
0.59
1.4
1.5
%
73.4
73.1
0.07
102
460
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
27
106
1.30
0.58
1.0
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
73
321
1.17
0.57
1.3
1.2
—
—
—
0
0
(44806071)
48
203
1.21
0.57
1.1
1.1
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
48
203
1.21
0.57
1.5
1.3
nmol/l
0.2
0.2
0.03
30
139
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
30
120
1.28
0.57
2.3
2.8
pmol/l
144.1
61.0
—
10
44
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
73
322
1.16
0.56
1.3
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
73
322
1.16
0.56
1.3
1.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
160
743
1.10
0.55
1.8
2.0
%
153.0
143.2
0.72
149
700
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
754
4033
0.96
0.55
1.5
1.5
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
6
19
1.62
0.55
1.0
1.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
6
19
1.62
0.55
1.0
1.0
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
26
170
0.78
0.54
1.0
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
37
232
0.82
0.54
1.1
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
38
158
1.23
0.54
1.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
275
1311
1.07
0.53
1.3
1.4
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
52
224
1.19
0.53
5.6
2.7
umol/l
40.6
41.0
0.06
41
189
(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid
12
88
0.70
0.52
1.1
1.3
%
1.0
1.4
—
6
55
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
255
1214
1.08
0.52
1.6
1.9
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
203
959
1.08
0.50
1.1
1.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
1863
9303
1.03
0.50
3.7
3.5
mmol/l
25.2
25.2
0.06
1790
9047
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
13
46
1.45
0.50
1.1
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
71
417
0.87
0.50
2.2
2.4
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
34
141
1.24
0.50
1.0
1.0
u/ml
0.1
0.2
1.07
22
95
(4281824)
354
1924
0.94
0.50
1.2
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
210
1162
0.93
0.50
2.0
2.1
min
503.6
494.1
0.72
146
881
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
151
705
1.10
0.49
1.1
1.1
ng/l
386.4
420.3
0.06
39
177
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
23
91
1.29
0.49
5.0
4.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
234
1288
0.93
0.49
1.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
36
151
1.22
0.49
1.1
1.2
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
21
82
1.31
0.49
1.1
1.2
g/l
0.1
0.1
0.86
16
60
(3036603) Volume of Urine
230
1266
0.93
0.48
1.7
1.6
ml
1947.9
1953.0
0.01
46
342
(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum
14
51
1.41
0.48
1.1
1.0
u/ml
0.2
0.8
—
7
19
(3008536) Aspergillus sp Ab [Presence] in Serum
75
338
1.14
0.46
2.2
2.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
593
3169
0.96
0.45
1.5
1.5
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
12
43
1.43
0.45
1.4
1.0
mmol/l
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
137
641
1.10
0.44
1.1
1.2
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
34
144
1.21
0.43
5.4
4.8
—
—
—
0
0
(3019529) Immunofixation for Cerebral spinal fluid
0
9
0.00
0.43
0.0
1.3
—
—
—
0
0
(3002814) Trichinella spiralis Ab [Titer] in Serum
5
16
1.60
0.43
1.0
1.0
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
78
355
1.13
0.42
1.2
1.2
%
70.4
73.9
0.25
30
104
(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum
0
10
0.00
0.42
0.0
1.2
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
22
89
1.27
0.41
1.3
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
169
802
1.08
0.41
1.1
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
54
241
1.15
0.40
1.0
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
272
1316
1.06
0.39
1.4
1.4
umol/l
12.6
12.5
0.13
256
1248
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
43
189
1.17
0.38
2.3
2.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
197
944
1.07
0.38
1.1
1.1
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
22
139
0.81
0.38
1.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
6
20
1.54
0.38
1.0
1.1
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
6
20
1.54
0.38
1.2
1.0
titre
1473.3
2352.5
—
6
20
(40765089) Chromosome analysis panel - Blood by G-banded
100
562
0.91
0.38
1.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
69
315
1.12
0.37
6.3
5.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
260
1259
1.06
0.37
1.1
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
363
1948
0.95
0.37
1.4
1.4
ug/l
3.5
4.0
0.41
320
1689
(3013336) Amino acids [Identifier] in Serum or Plasma
16
63
1.30
0.37
3.8
2.2
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
223
1075
1.06
0.37
1.1
1.1
u/ml
13.9
2.1
0.53
58
262
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
65
296
1.12
0.37
1.3
1.1
mmol/l
21.5
19.9
1.98
52
264
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
94
529
0.91
0.37
5.9
6.3
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
94
529
0.91
0.37
2.9
3.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
82
379
1.11
0.36
3.0
2.8
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
114
536
1.09
0.36
1.2
1.1
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
40
176
1.16
0.36
1.3
1.7
nmol/l
4.3
7.5
0.77
40
167
(3018851) Theophylline [Moles/volume] in Serum or Plasma
36
157
1.17
0.36
1.6
1.9
umol/l
42.0
44.1
0.22
36
157
(3013762) Body weight Measured
17
68
1.28
0.35
1.4
1.1
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
6
22
1.40
0.35
1.2
1.5
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
113
532
1.09
0.35
1.5
1.5
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
53
307
0.88
0.35
1.1
1.1
—
—
—
0
0
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
31
134
1.19
0.34
1.3
1.6
mg/l
2.5
3.0
0.24
13
93
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
31
134
1.19
0.34
1.3
1.6
mg/l
1.0
1.6
0.37
16
81
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
31
134
1.19
0.34
1.3
1.6
mg/l
1.8
2.4
0.26
15
81
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
31
134
1.19
0.34
1.3
1.6
mg/l
1.7
2.6
0.42
18
84
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
31
134
1.19
0.34
1.3
1.6
mg/l
0.8
0.7
0.04
15
88
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
31
134
1.19
0.34
1.3
1.6
mg/l
2.7
2.5
0.06
19
95
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
31
134
1.19
0.34
1.3
1.6
mg/l
3.6
2.6
0.30
18
95
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
31
134
1.19
0.34
1.3
1.6
mg/l
3.2
2.0
0.41
18
97
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
31
134
1.19
0.34
1.3
1.6
mg/l
4.7
4.5
0.03
16
86
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
6
23
1.34
0.34
1.0
1.1
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
6
23
1.34
0.34
1.0
1.1
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
32
139
1.18
0.34
1.1
1.2
%
32.1
19.2
—
10
32
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
19
120
0.81
0.34
1.2
1.4
%
31.0
40.4
0.37
12
76
(3051651) Icteric interference index of Serum or Plasma
246
1194
1.06
0.34
3.2
4.2
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
25
106
1.21
0.33
1.0
1.3
—
114.0
—
0
5
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
12
46
1.34
0.33
1.1
1.1
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
50
226
1.13
0.33
1.3
1.2
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
17
69
1.26
0.32
1.6
1.1
%
1.5
1.4
0.30
17
69
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
17
69
1.26
0.32
3.8
4.1
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
35
154
1.16
0.32
1.0
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
35
154
1.16
0.32
1.1
1.1
umol/24h
1.8
1.8
0.02
35
154
(3041184) Isoniazid [Presence] in Urine
7
26
1.38
0.32
3.0
2.2
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
13
51
1.31
0.31
1.2
1.1
—
—
—
0
0
(3024316) Viscosity of Plasma
16
102
0.80
0.31
1.4
1.7
mpas
1.4
1.8
—
10
55
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
76
354
1.10
0.31
1.2
1.2
%
77.2
90.6
2.03
30
107
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
57
325
0.90
0.30
1.9
2.1
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
50
287
0.89
0.30
1.1
1.2
u/ml
8.6
6.3
0.10
36
209
(3033799) Differential panel - Peritoneal fluid
118
563
1.07
0.29
1.9
1.9
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
47
214
1.13
0.29
1.1
1.2
—
—
—
0
0
(3022670) pH of Venous cord blood
9
62
0.74
0.28
1.1
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
8
32
1.28
0.28
2.4
2.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
188
912
1.06
0.28
1.5
1.4
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
34
199
0.88
0.28
2.7
2.7
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
445
2357
0.97
0.27
1.9
1.9
ug/l
22.2
26.5
1.09
436
2304
(3014891) Appearance of Pleural fluid
63
293
1.10
0.27
1.5
1.6
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
11
43
1.31
0.27
1.3
1.4
nmol/l
296.2
548.6
1.53
11
43
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
119
570
1.07
0.27
2.0
2.0
%
168.0
171.1
0.12
111
544
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
14
57
1.26
0.27
1.1
1.1
g/l
0.2
0.2
—
9
49
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
31
138
1.15
0.26
1.3
1.6
mg/l
1.8
1.7
0.04
17
84
(4034850)
1223
6146
1.02
0.26
10.6
9.7
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
169
913
0.95
0.26
1.2
1.2
—
—
—
0
0
(21494227) Amikacin free [Mass/volume] in Serum or Plasma
12
48
1.28
0.26
4.9
4.9
mg/l
4.1
7.8
—
7
38
(3006969) Lambda light chains [Mass/volume] in Urine
12
48
1.28
0.26
1.0
1.1
g/l
0.0
0.0
—
5
18
(3017509) Phencyclidine [Presence] in Urine
39
177
1.13
0.26
2.0
1.7
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
9
38
1.21
0.25
1.0
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
14
88
0.81
0.25
7.0
11.9
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
6
43
0.71
0.25
1.0
1.1
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
16
67
1.22
0.25
3.6
4.1
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
126
685
0.94
0.24
2.1
1.8
e6/l
7007.9
2791.9
0.28
82
458
(3025549) Creatine [Moles/time] in 24 hour Urine
31
139
1.14
0.24
1.4
1.4
—
13.6
—
0
7
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
71
335
1.09
0.24
1.5
1.8
ug/l
1.8
4.9
1.20
33
205
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
48
222
1.11
0.24
1.5
1.5
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
17
104
0.84
0.24
1.0
1.1
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
5
19
1.35
0.24
1.0
1.1
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
106
509
1.07
0.24
1.9
2.2
e6/l
800.5
1066.9
0.14
59
272
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
18
77
1.20
0.23
11.7
9.5
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
5
20
1.28
0.23
1.4
1.4
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
5
20
1.28
0.23
1.4
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
13018
66385
1.01
0.23
2.8
2.7
—
—
—
0
0
(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.22
0.0
1.0
—
7.3
—
0
6
(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG
0
6
0.00
0.22
0.0
2.5
—
4.0
—
0
6
(3010370) Gastrin [Moles/volume] in Serum or Plasma
55
258
1.09
0.22
1.7
1.8
pmol/l
33.0
52.9
0.97
45
216
(3030703) Everolimus [Mass/volume] in Blood
0
7
0.00
0.22
0.0
17.9
—
4.9
—
0
7
(3042628) Porphyrins [Moles/volume] in Urine
0
7
0.00
0.22
0.0
1.1
—
—
—
0
0
(3015057) Respiratory syncytial virus Ab [Titer] in Serum
0
7
0.00
0.22
0.0
1.0
—
—
—
0
0
(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum
0
7
0.00
0.22
0.0
1.1
—
—
—
0
0
(3013931) Oligosaccharides [Presence] in Urine
0
7
0.00
0.22
0.0
1.0
—
—
—
0
0
(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum
0
7
0.00
0.22
0.0
1.1
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
18
78
1.18
0.21
1.1
1.0
—
—
—
0
0
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
21
124
0.87
0.21
1.7
1.4
u/ml
39.0
2.1
0.50
14
106
(36303858) Crystals [Presence] in Urine
6
25
1.23
0.20
1.2
1.1
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
85
408
1.07
0.20
1.4
1.4
g/l
29.0
30.7
0.18
58
316
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
17
102
0.85
0.20
1.2
1.4
%
16.1
11.6
0.40
11
70
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
1714
8668
1.01
0.20
4.2
4.1
%
49.0
47.8
1.15
1692
8573
(3001686) Cold agglutinin [Titer] in Serum or Plasma
65
309
1.08
0.20
1.2
1.4
titre
113.5
169.8
0.24
13
36
(3011841) English Walnut IgE Ab [Units/volume] in Serum
30
172
0.89
0.20
1.0
1.1
u/ml
18.1
5.2
0.37
22
138
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
39
181
1.10
0.19
2.4
3.2
mg/l
1.3
1.2
0.13
29
125
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
41
191
1.10
0.19
1.0
1.0
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
47
262
0.92
0.19
1.2
1.4
%
28.4
23.1
0.43
32
208
(43055459) Dabigatran [Mass/volume] in Serum or Plasma
13
55
1.21
0.19
1.5
1.7
ug/l
94.8
116.9
—
8
33
(3027570) Oxalate [Moles/time] in 24 hour Urine
25
113
1.13
0.19
1.6
1.3
umol/24h
348.7
290.9
0.80
25
113
(3000285) Sodium [Moles/volume] in Blood
46
256
0.92
0.18
1.1
1.2
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
7
31
1.16
0.18
1.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
42
197
1.09
0.18
1.0
1.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
16
70
1.17
0.17
1.1
1.6
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
16
70
1.17
0.17
1.1
1.0
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
8
35
1.17
0.17
2.8
3.3
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
12
51
1.21
0.17
1.1
1.1
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
25
143
0.90
0.16
1.0
1.2
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
8
36
1.14
0.16
1.0
1.1
—
—
—
0
0
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
29
164
0.91
0.16
1.0
1.1
u/ml
0.1
0.6
0.86
15
88
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
9
39
1.18
0.16
1.8
1.2
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
52
248
1.07
0.16
1.4
1.5
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
32
149
1.10
0.16
1.5
1.5
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
112
599
0.96
0.15
2.0
1.7
e6/l
5522.7
12990.2
1.15
58
307
(3049242) von Willebrand panel - Platelet poor plasma
12
52
1.18
0.14
2.1
1.7
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
21
96
1.12
0.14
1.1
1.1
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
22
101
1.12
0.14
2.0
1.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
79
385
1.05
0.13
1.1
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
853
4423
0.99
0.12
1.4
1.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
727
3675
1.01
0.12
2.2
1.9
nmol/l
0.8
0.8
0.04
600
3112
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
112
553
1.04
0.12
1.2
1.2
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
55
267
1.06
0.11
1.3
1.3
mmol/l
0.8
1.5
0.96
38
166
(3052592) Norovirus Ag [Presence] in Stool
72
353
1.04
0.11
1.3
1.4
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
18
83
1.11
0.10
1.1
1.1
mmol/l
8.1
8.7
1.21
18
83
(3002079) Sodium [Moles/time] in 24 hour Urine
5
22
1.16
0.10
1.2
1.0
mmol/24h
123.2
157.6
—
5
22
(3011897) Casein IgE Ab [Units/volume] in Serum
54
263
1.05
0.10
1.4
1.3
u/ml
9.5
7.1
0.11
12
64
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
23
108
1.09
0.10
1.2
1.1
u/field
1.0
1.3
1.76
14
74
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
82
404
1.04
0.10
1.1
1.1
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
28
133
1.08
0.10
1.0
1.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
41
198
1.06
0.10
1.3
1.2
—
—
—
0
0
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
32
153
1.07
0.10
1.7
2.2
%
60.3
59.3
0.05
22
93
(3026692) Albumin [Mass/volume] in Peritoneal fluid
88
467
0.97
0.09
1.4
1.3
g/l
15.3
13.5
1.07
69
350
(3044007) Cell count panel - Peritoneal fluid
104
550
0.97
0.09
2.1
1.9
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
185
969
0.98
0.09
1.0
1.1
u/ml
3.5
0.6
0.58
30
122
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
46
224
1.05
0.09
2.2
2.6
pmol/l
82.1
72.0
0.21
39
198
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
5
31
0.83
0.08
1.0
1.3
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
36
195
0.95
0.08
1.1
1.1
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
7
32
1.12
0.08
6.4
5.7
mmol/l
0.2
0.3
—
7
32
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
1695
8632
1.01
0.08
3.3
3.5
u/ml
62.2
61.8
0.01
1615
8393
(3012989) Citrate [Moles/time] in 24 hour Urine
7
42
0.85
0.07
1.1
1.3
mmol/24h
1.9
2.3
—
7
42
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
9
44
1.05
0.07
1.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
21
100
1.08
0.07
1.1
1.2
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
19
90
1.08
0.07
1.1
1.1
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
8
49
0.84
0.07
1.0
1.0
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
49
241
1.04
0.07
1.1
1.3
%
53.6
52.0
0.07
21
104
(3032743) Legionella sp IgG Ab [Presence] in Serum
25
136
0.94
0.06
1.0
1.2
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
45
240
0.96
0.06
1.2
2.4
mmol/l
6.3
7.5
2.40
12
116
(21494567) Legionella sp IgM Ab [Presence] in Serum
26
141
0.94
0.06
1.0
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
182
917
1.02
0.06
3.2
3.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
586
2978
1.01
0.06
1.2
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
84
441
0.98
0.05
1.2
1.1
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
24
116
1.06
0.05
1.3
1.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
106
532
1.02
0.05
1.3
1.2
—
—
—
0
0
(3042951) Complement C1q Ab [Units/volume] in Serum
15
71
1.08
0.05
1.1
1.1
u/ml
24.4
24.0
—
5
12
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
14
66
1.09
0.05
1.1
1.1
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
326
1686
0.99
0.05
1.2
1.2
nmol/l
359.3
358.1
0.03
275
1376
(40758292) HTLV I+II Ab panel - Serum
56
295
0.97
0.04
1.4
1.4
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
33
176
0.96
0.04
1.0
1.1
u/ml
2.8
4.8
0.32
24
139
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
195
987
1.01
0.04
2.3
2.5
%
95.8
97.6
0.30
185
940
(3016273) Islet cell 512 Ab [Units/volume] in Serum
24
129
0.95
0.04
1.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
61
305
1.02
0.04
1.3
1.2
—
—
—
0
0
(3003577) Lead [Moles/volume] in Blood
27
144
0.96
0.03
1.3
1.3
umol/l
0.1
0.2
—
8
47
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
29
143
1.04
0.03
1.0
1.1
u/ml
0.1
0.7
1.67
18
79
(3045683) HLA typing for celiac disease panel - Blood or Tissue
207
1070
0.99
0.03
1.0
1.0
—
—
—
0
0
(4038314)
23
123
0.96
0.03
1.1
1.2
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
30
159
0.97
0.03
1.0
1.1
u/ml
0.0
0.8
0.64
17
80
(3050794) Legionella sp Ab [Presence] in Serum
34
169
1.03
0.02
1.1
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
99
501
1.01
0.02
1.7
1.3
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
49
246
1.02
0.02
5.2
4.8
ug/min
40.1
52.7
1.01
40
196
(40758358) Immune stain study
16
78
1.05
0.01
1.0
1.0
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
45
235
0.98
0.01
1.4
1.3
u/l
785.1
76.3
0.52
32
162
(3016031) Almond IgE Ab [Units/volume] in Serum
19
101
0.96
0.01
1.0
1.1
u/ml
0.7
1.3
0.61
12
64
(3013862) HLA-DP [Type]
12
65
0.95
0.01
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
12
65
0.95
0.01
1.0
1.0
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
21
104
1.03
0.01
1.0
1.1
u/ml
5.0
6.6
0.22
15
63
(3005082) Progesterone [Moles/volume] in Serum or Plasma
148
762
0.99
0.00
1.4
1.4
nmol/l
33.1
31.6
0.23
128
704
(3041806) Other cells [#/volume] in Blood by Manual count
96
488
1.01
0.00
1.7
1.3
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
10
48
1.07
0.00
1.4
1.2
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
32
167
0.98
0.00
1.1
1.2
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
12
64
0.96
0.00
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
12
64
0.96
0.00
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
12
64
0.96
0.00
1.0
1.0
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
15
76
1.01
0.00
1.1
1.3
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
12
63
0.98
0.00
1.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
49
250
1.00
0.00
1.0
1.2
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
10
49
1.05
0.00
1.0
1.1
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
18
91
1.01
0.00
1.0
1.1
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
20
102
1.00
0.00
1.6
1.6
umol/l
0.9
0.7
0.42
13
81
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
24
123
1.00
0.00
1.7
2.2
%
8.6
17.1
1.32
13
61
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
30
156
0.99
0.00
1.2
1.3
ml/s/173m2
0.8
1.3
1.84
19
102
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
23
120
0.98
0.00
1.0
1.1
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
21
109
0.99
0.00
1.5
1.2
pmol/l
14.1
17.9
0.62
16
99
(3039744) RNA polymerase III Ab [Units/volume] in Serum
30
152
1.01
0.00
1.1
1.0
u/ml
3.9
6.0
—
8
14
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
16
84
0.98
0.00
1.0
1.0
—
—
—
0
0
(3049233) Organic acids panel - Urine
8
46
0.89
0.00
1.1
1.2
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
38
0.94
0.00
8.7
6.8
—
—
—
0
0
(3032641) Amino acids panel - Urine
5
28
0.91
0.00
1.6
1.2
—
—
—
0
0
(3003220) Varicella zoster virus IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
789.6
—
0
5
(3006567) Chloride [Moles/time] in 24 hour Urine
6
33
0.93
0.00
1.0
1.1
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
6
32
0.96
0.00
1.2
1.3
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
6
32
0.96
0.00
2.2
1.1
—
—
—
0
0
(3016072) Theophylline [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
5
29
0.88
0.00
1.2
1.1
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
8
45
0.91
0.00
1.1
1.1
—
—
—
0
0
(3017830) Gliadin IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: K11_DENTAL_OPER_ONLYAVO – Dental operations, only avohilmo
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).